primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
102667392,10266739,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,100,MG,,QD,2015,Q1,Blister,,2015,Q1,2,F,20140501.0,20150219.0,20140630,20150302,EXP,GB-MHRA-EYC 00112162,GB-ACCORD-024417,ACCORD,,60.0,YR,,M,Y,91.0,KG,20150302.0,N,MD,GB,GB,2015,Q1,Adult
102667392,10266739,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,100,MG,,QD,2015,Q1,Depressed mood,,2015,Q1,2,F,20140501.0,20150219.0,20140630,20150302,EXP,GB-MHRA-EYC 00112162,GB-ACCORD-024417,ACCORD,,60.0,YR,,M,Y,91.0,KG,20150302.0,N,MD,GB,GB,2015,Q1,Adult
102667392,10266739,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,100,MG,,QD,2015,Q1,Drug interaction,,2015,Q1,2,F,20140501.0,20150219.0,20140630,20150302,EXP,GB-MHRA-EYC 00112162,GB-ACCORD-024417,ACCORD,,60.0,YR,,M,Y,91.0,KG,20150302.0,N,MD,GB,GB,2015,Q1,Adult
102667392,10266739,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,100,MG,,QD,2015,Q1,Self-injurious ideation,,2015,Q1,2,F,20140501.0,20150219.0,20140630,20150302,EXP,GB-MHRA-EYC 00112162,GB-ACCORD-024417,ACCORD,,60.0,YR,,M,Y,91.0,KG,20150302.0,N,MD,GB,GB,2015,Q1,Adult
104886723,10488672,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,N,,,204042.0,,,CAPSULE,,2015,Q1,Breast cancer,,2015,Q1,3,F,20150312.0,20150317.0,20141002,20150326,PER,,US-JNJFOC-20140919106,JANSSEN,,61.0,YR,A,M,Y,168.5,KG,20150326.0,N,MD,US,US,2015,Q1,Adult
104886723,10488672,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,N,,,76479.0,300,MG,CAPSULE,,2015,Q1,Breast cancer,,2015,Q1,3,F,20150312.0,20150317.0,20141002,20150326,PER,,US-JNJFOC-20140919106,JANSSEN,,61.0,YR,A,M,Y,168.5,KG,20150326.0,N,MD,US,US,2015,Q1,Adult
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Anaemia,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Angina pectoris,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Asthenia,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Chest pain,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Dizziness,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Dyspnoea,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Fatigue,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Gastritis,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Gastrointestinal haemorrhage,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Haematochezia,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Heart rate irregular,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,International normalised ratio increased,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Nodule,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Palpitations,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Rhinorrhoea,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Supraventricular tachycardia,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Toxicity to various agents,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105389814,10538981,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"100 MG, QD",,,,U,,,,100,MG,,QD,2015,Q1,Transfusion,,2015,Q1,4,F,201409.0,20141229.0,20141023,20150109,EXP,,US-ACTELION-A-NJ2014-106969,ACTELION,,69.0,YR,E,F,Y,,,20150109.0,N,OT,US,US,2015,Q1,Elderly
105848804,10584880,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,U, EATK006,,204042.0,300,MG,CAPSULE,,2015,Q1,Nephropathy toxic,,2015,Q1,4,F,20141029.0,20150206.0,20141114,20150317,PER,,GB-JNJFOC-20141021305,JANSSEN,,73.0,YR,E,M,Y,66.0,KG,20150317.0,N,MD,GB,GB,2015,Q1,Elderly
105848804,10584880,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,U, EATK006,,76479.0,100,MG,CAPSULE,,2015,Q1,Nephropathy toxic,,2015,Q1,4,F,20141029.0,20150206.0,20141114,20150317,PER,,GB-JNJFOC-20141021305,JANSSEN,,73.0,YR,E,M,Y,66.0,KG,20150317.0,N,MD,GB,GB,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Anaemia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Cough,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Dehydration,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Hypoglycaemia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Hyponatraemia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Hypovolaemia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Liver function test abnormal,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Liver injury,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,300,MG,CAPSULE,,2015,Q1,Pyrexia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Anaemia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Cough,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Dehydration,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Hypoglycaemia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Hyponatraemia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Hypovolaemia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Liver function test abnormal,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Liver injury,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106783862,10678386,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Pyrexia,,2015,Q1,2,F,20141210.0,20150114.0,20141229,20150128,EXP,,US-JNJFOC-20141212397,JANSSEN,,73.0,YR,E,M,Y,93.2,KG,20150128.0,N,MD,US,US,2015,Q1,Elderly
106790543,10679054,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q1,Arthralgia,,2015,Q1,3,F,2014.0,20150218.0,20141229,20150225,PER,,US-PFIZER INC-2014352590,PFIZER,,70.0,YR,,F,Y,85.0,KG,20150225.0,N,OT,US,US,2015,Q1,Elderly
106790543,10679054,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q1,Drug ineffective,,2015,Q1,3,F,2014.0,20150218.0,20141229,20150225,PER,,US-PFIZER INC-2014352590,PFIZER,,70.0,YR,,F,Y,85.0,KG,20150225.0,N,OT,US,US,2015,Q1,Elderly
106790543,10679054,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q1,Musculoskeletal stiffness,,2015,Q1,3,F,2014.0,20150218.0,20141229,20150225,PER,,US-PFIZER INC-2014352590,PFIZER,,70.0,YR,,F,Y,85.0,KG,20150225.0,N,OT,US,US,2015,Q1,Elderly
106790543,10679054,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q1,Pain,,2015,Q1,3,F,2014.0,20150218.0,20141229,20150225,PER,,US-PFIZER INC-2014352590,PFIZER,,70.0,YR,,F,Y,85.0,KG,20150225.0,N,OT,US,US,2015,Q1,Elderly
106790543,10679054,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q1,Peripheral swelling,,2015,Q1,3,F,2014.0,20150218.0,20141229,20150225,PER,,US-PFIZER INC-2014352590,PFIZER,,70.0,YR,,F,Y,85.0,KG,20150225.0,N,OT,US,US,2015,Q1,Elderly
106790543,10679054,29,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q1,Rheumatoid nodule,,2015,Q1,3,F,2014.0,20150218.0,20141229,20150225,PER,,US-PFIZER INC-2014352590,PFIZER,,70.0,YR,,F,Y,85.0,KG,20150225.0,N,OT,US,US,2015,Q1,Elderly
106957052,10695705,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, EEZ5100,,204042.0,100,MG,TABLET,QD,2015,Q1,Blister,,2015,Q1,2,F,20141203.0,20150129.0,20150107,20150209,EXP,,GB-JNJFOC-20150101586,JANSSEN,,45.0,YR,A,M,Y,109.4,KG,20150209.0,N,OT,GB,GB,2015,Q1,Adult
106957052,10695705,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, EEZ5100,,204042.0,100,MG,TABLET,QD,2015,Q1,Candida infection,,2015,Q1,2,F,20141203.0,20150129.0,20150107,20150209,EXP,,GB-JNJFOC-20150101586,JANSSEN,,45.0,YR,A,M,Y,109.4,KG,20150209.0,N,OT,GB,GB,2015,Q1,Adult
106957052,10695705,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, EEZ5100,,204042.0,100,MG,TABLET,QD,2015,Q1,Dry skin,,2015,Q1,2,F,20141203.0,20150129.0,20150107,20150209,EXP,,GB-JNJFOC-20150101586,JANSSEN,,45.0,YR,A,M,Y,109.4,KG,20150209.0,N,OT,GB,GB,2015,Q1,Adult
106957052,10695705,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, EEZ5100,,204042.0,100,MG,TABLET,QD,2015,Q1,Papule,,2015,Q1,2,F,20141203.0,20150129.0,20150107,20150209,EXP,,GB-JNJFOC-20150101586,JANSSEN,,45.0,YR,A,M,Y,109.4,KG,20150209.0,N,OT,GB,GB,2015,Q1,Adult
106957052,10695705,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, EEZ5100,,204042.0,100,MG,TABLET,QD,2015,Q1,Scrotal cyst,,2015,Q1,2,F,20141203.0,20150129.0,20150107,20150209,EXP,,GB-JNJFOC-20150101586,JANSSEN,,45.0,YR,A,M,Y,109.4,KG,20150209.0,N,OT,GB,GB,2015,Q1,Adult
106957052,10695705,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, EEZ5100,,204042.0,100,MG,TABLET,QD,2015,Q1,Scrotal disorder,,2015,Q1,2,F,20141203.0,20150129.0,20150107,20150209,EXP,,GB-JNJFOC-20150101586,JANSSEN,,45.0,YR,A,M,Y,109.4,KG,20150209.0,N,OT,GB,GB,2015,Q1,Adult
106957052,10695705,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, EEZ5100,,204042.0,100,MG,TABLET,QD,2015,Q1,Skin exfoliation,,2015,Q1,2,F,20141203.0,20150129.0,20150107,20150209,EXP,,GB-JNJFOC-20150101586,JANSSEN,,45.0,YR,A,M,Y,109.4,KG,20150209.0,N,OT,GB,GB,2015,Q1,Adult
106957052,10695705,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, EEZ5100,,204042.0,100,MG,TABLET,QD,2015,Q1,Skin fissures,,2015,Q1,2,F,20141203.0,20150129.0,20150107,20150209,EXP,,GB-JNJFOC-20150101586,JANSSEN,,45.0,YR,A,M,Y,109.4,KG,20150209.0,N,OT,GB,GB,2015,Q1,Adult
107120101,10712010,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"300 MG, QD",,,,U,,,,300,MG,,QD,2015,Q1,Skin infection,,2015,Q1,1,I,,20140925.0,20150114,20150114,PER,,US-ALLERGAN-1421018US,ALLERGAN,,49.0,YR,,F,Y,,,20150114.0,N,MD,COUNTRY NOT SPECIFIED,US,2015,Q1,Adult
107120101,10712010,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,"300 MG, QD",,,,U,,,,300,MG,,QD,2015,Q1,Staphylococcal infection,,2015,Q1,1,I,,20140925.0,20150114,20150114,PER,,US-ALLERGAN-1421018US,ALLERGAN,,49.0,YR,,F,Y,,,20150114.0,N,MD,COUNTRY NOT SPECIFIED,US,2015,Q1,Adult
107342331,10734233,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,,,,,N,,,,300,MG,TABLET,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,,20150115.0,20150123,20150123,EXP,,US-JNJFOC-20150112178,JANSSEN,,26.0,YR,A,F,Y,,,20150123.0,N,MD,US,US,2015,Q1,Young Adult
107342331,10734233,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,,,,,N,,,,300,MG,TABLET,,2015,Q1,Off label use,,2015,Q1,1,I,,20150115.0,20150123,20150123,EXP,,US-JNJFOC-20150112178,JANSSEN,,26.0,YR,A,F,Y,,,20150123.0,N,MD,US,US,2015,Q1,Young Adult
107342331,10734233,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,,,,,N,,,204042.0,300,MG,TABLET,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,,20150115.0,20150123,20150123,EXP,,US-JNJFOC-20150112178,JANSSEN,,26.0,YR,A,F,Y,,,20150123.0,N,MD,US,US,2015,Q1,Young Adult
107342331,10734233,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,,,,,N,,,204042.0,300,MG,TABLET,,2015,Q1,Off label use,,2015,Q1,1,I,,20150115.0,20150123,20150123,EXP,,US-JNJFOC-20150112178,JANSSEN,,26.0,YR,A,F,Y,,,20150123.0,N,MD,US,US,2015,Q1,Young Adult
107478803,10747880,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,1 PILL,,,,N, 209005,,204042,300,MG,CAPSULE,QD,2015,Q1,Diabetic ketoacidosis,,2015,Q1,3,F,20150107.0,20150206.0,20150129,20150217,EXP,,US-JNJFOC-20150107015,JANSSEN,,41.0,YR,A,M,Y,,,20150217.0,N,MD,US,US,2015,Q1,Adult
107478803,10747880,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, 209005,,076479,,,CAPSULE,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,3,F,20150107.0,20150206.0,20150129,20150217,EXP,,US-JNJFOC-20150107015,JANSSEN,,41.0,YR,A,M,Y,,,20150217.0,N,MD,US,US,2015,Q1,Adult
107502351,10750235,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,,,,,D,,,,,,,,2015,Q1,Rash,,2015,Q1,1,I,,20150121.0,20150129,20150129,PER,,US-ASTRAZENECA-2015SE07912,ASTRAZENECA,,54.0,YR,,F,Y,,,20150130.0,N,CN,US,US,2015,Q1,Adult
107845843,10784584,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,1 TABLET BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100,MG,TABLET,,2015,Q1,Myocardial infarction,,2015,Q1,3,F,20150124.0,20150212.0,20150211,20150227,EXP,,JP-JNJFOC-20150204403,JANSSEN,,67.0,YR,E,M,Y,79.0,KG,20150227.0,N,OT,JP,JP,2015,Q1,Elderly
107867821,10786782,1,PS,BLINDED; CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, UNKNOWN,,204042.0,,,CAPSULE,,2015,Q1,Acute leukaemia,,2015,Q1,1,I,20150107.0,20150127.0,20150211,20150211,EXP,,US-JNJFOC-20150121474,JANSSEN,,74.0,YR,E,M,Y,97.0,KG,20150211.0,N,MD,US,US,2015,Q1,Elderly
107867821,10786782,1,PS,BLINDED; CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, UNKNOWN,,204042.0,,,CAPSULE,,2015,Q1,Oropharyngeal pain,,2015,Q1,1,I,20150107.0,20150127.0,20150211,20150211,EXP,,US-JNJFOC-20150121474,JANSSEN,,74.0,YR,E,M,Y,97.0,KG,20150211.0,N,MD,US,US,2015,Q1,Elderly
107867821,10786782,1,PS,BLINDED; CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, UNKNOWN,,204042.0,,,CAPSULE,,2015,Q1,Pharyngeal oedema,,2015,Q1,1,I,20150107.0,20150127.0,20150211,20150211,EXP,,US-JNJFOC-20150121474,JANSSEN,,74.0,YR,E,M,Y,97.0,KG,20150211.0,N,MD,US,US,2015,Q1,Elderly
107867821,10786782,2,SS,BLINDED; CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, UNKNOWN,,76479.0,,,CAPSULE,,2015,Q1,Acute leukaemia,,2015,Q1,1,I,20150107.0,20150127.0,20150211,20150211,EXP,,US-JNJFOC-20150121474,JANSSEN,,74.0,YR,E,M,Y,97.0,KG,20150211.0,N,MD,US,US,2015,Q1,Elderly
107867821,10786782,2,SS,BLINDED; CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, UNKNOWN,,76479.0,,,CAPSULE,,2015,Q1,Oropharyngeal pain,,2015,Q1,1,I,20150107.0,20150127.0,20150211,20150211,EXP,,US-JNJFOC-20150121474,JANSSEN,,74.0,YR,E,M,Y,97.0,KG,20150211.0,N,MD,US,US,2015,Q1,Elderly
107867821,10786782,2,SS,BLINDED; CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, UNKNOWN,,76479.0,,,CAPSULE,,2015,Q1,Pharyngeal oedema,,2015,Q1,1,I,20150107.0,20150127.0,20150211,20150211,EXP,,US-JNJFOC-20150121474,JANSSEN,,74.0,YR,E,M,Y,97.0,KG,20150211.0,N,MD,US,US,2015,Q1,Elderly
107893771,10789377,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"100 MG, UNK",,,,D,,,,100,MG,,QD,2015,Q1,Dysuria,,2015,Q1,1,I,201412.0,20150123.0,20150212,20150212,PER,,US-ELI_LILLY_AND_COMPANY-US201501008663,ELI LILLY AND CO,,63.0,YR,,M,Y,117.1,KG,20150212.0,N,CN,US,US,2015,Q1,Adult
107893771,10789377,2,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"100 MG, UNK",,,,D,,,,100,MG,,QD,2015,Q1,Renal pain,,2015,Q1,1,I,201412.0,20150123.0,20150212,20150212,PER,,US-ELI_LILLY_AND_COMPANY-US201501008663,ELI LILLY AND CO,,63.0,YR,,M,Y,117.1,KG,20150212.0,N,CN,US,US,2015,Q1,Adult
108136232,10813623,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,,,,,U,,,204042.0,,,TABLET,,2015,Q1,Cholestatic liver injury,,2015,Q1,2,F,,20150220.0,20150218,20150304,EXP,,US-JNJFOC-20150209284,JANSSEN,"MIAO CL, MOWERY A, LI J, KHARA H, JOHAL  A, INVERSO N, ET AL. A CASE OF DRUG-INDUCED LIVER INJURY BY THE NEW DIABETES DRUG CANAGLIFLOZIN. AMERICAN JOURNAL OF GASTROENTEROLOGY 79TH ANNUAL SCIENTIFIC MEETING  22-OCT-2014;109:S387-S388.",49.0,YR,A,M,Y,,,20150304.0,N,MD,US,US,2015,Q1,Adult
108490901,10849090,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,"100 MG, DAILY",,,,U,,,,100.0,MG,,,2015,Q1,Blister,,2015,Q1,1,I,20140501.0,20140623.0,20150221,20150221,EXP,,GB-AUROBINDO-AUR-APL-2014-06837,AUROBINDO,,60.0,YR,,M,Y,91.0,KG,20150221.0,N,MD,GB,GB,2015,Q1,Adult
108490901,10849090,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,"100 MG, DAILY",,,,U,,,,100.0,MG,,,2015,Q1,Depressed mood,,2015,Q1,1,I,20140501.0,20140623.0,20150221,20150221,EXP,,GB-AUROBINDO-AUR-APL-2014-06837,AUROBINDO,,60.0,YR,,M,Y,91.0,KG,20150221.0,N,MD,GB,GB,2015,Q1,Adult
108490901,10849090,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,"100 MG, DAILY",,,,U,,,,100.0,MG,,,2015,Q1,Self-injurious ideation,,2015,Q1,1,I,20140501.0,20140623.0,20150221,20150221,EXP,,GB-AUROBINDO-AUR-APL-2014-06837,AUROBINDO,,60.0,YR,,M,Y,91.0,KG,20150221.0,N,MD,GB,GB,2015,Q1,Adult
108562111,10856211,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,,,,,U, UNKNOWN,,204042.0,,,TABLET,,2015,Q1,Insomnia,,2015,Q1,1,I,20141004.0,20150212.0,20150223,20150223,EXP,,GB-JNJFOC-20150210087,JANSSEN,,62.0,YR,A,M,Y,95.31,KG,20150223.0,N,MD,GB,GB,2015,Q1,Adult
108562111,10856211,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,UNKNOWN,,,,,U, UNKNOWN,,204042.0,,,TABLET,,2015,Q1,Paranoia,,2015,Q1,1,I,20141004.0,20150212.0,20150223,20150223,EXP,,GB-JNJFOC-20150210087,JANSSEN,,62.0,YR,A,M,Y,95.31,KG,20150223.0,N,MD,GB,GB,2015,Q1,Adult
108726691,10872669,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"300 MG, QD",,,,D,,,,300,MG,,QD,2015,Q1,Acidosis,,2015,Q1,1,I,,20150213.0,20150227,20150227,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-010812,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20150227.0,N,CN,DE,JP,2015,Q1,Elderly
108726691,10872669,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"300 MG, QD",,,,D,,,,300,MG,,QD,2015,Q1,Dehydration,,2015,Q1,1,I,,20150213.0,20150227,20150227,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-010812,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20150227.0,N,CN,DE,JP,2015,Q1,Elderly
108726691,10872669,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"300 MG, QD",,,,D,,,,300,MG,,QD,2015,Q1,Diarrhoea,,2015,Q1,1,I,,20150213.0,20150227,20150227,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-010812,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20150227.0,N,CN,DE,JP,2015,Q1,Elderly
108726691,10872669,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"300 MG, QD",,,,D,,,,300,MG,,QD,2015,Q1,Gastroenteritis,,2015,Q1,1,I,,20150213.0,20150227,20150227,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-010812,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20150227.0,N,CN,DE,JP,2015,Q1,Elderly
108726691,10872669,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"300 MG, QD",,,,D,,,,300,MG,,QD,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,,20150213.0,20150227,20150227,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-010812,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20150227.0,N,CN,DE,JP,2015,Q1,Elderly
108726691,10872669,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"300 MG, QD",,,,D,,,,300,MG,,QD,2015,Q1,Renal impairment,,2015,Q1,1,I,,20150213.0,20150227,20150227,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-010812,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20150227.0,N,CN,DE,JP,2015,Q1,Elderly
108726691,10872669,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,"300 MG, QD",,,,D,,,,300,MG,,QD,2015,Q1,Vomiting,,2015,Q1,1,I,,20150213.0,20150227,20150227,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-010812,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20150227.0,N,CN,DE,JP,2015,Q1,Elderly
108731866,10873186,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,100/300 MG,,,,N, 4369273,,204042.0,,,CAPSULE,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,6,F,20150216.0,20150313.0,20150227,20150320,EXP,,US-JNJFOC-20150214720,JANSSEN,,28.0,YR,A,F,Y,72.58,KG,20150320.0,N,MD,US,US,2015,Q1,Young Adult
108731866,10873186,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N, 4369273,,76479.0,,,CAPSULE,,2015,Q1,Diabetic ketoacidosis,,2015,Q1,6,F,20150216.0,20150313.0,20150227,20150320,EXP,,US-JNJFOC-20150214720,JANSSEN,,28.0,YR,A,F,Y,72.58,KG,20150320.0,N,MD,US,US,2015,Q1,Young Adult
108776426,10877642,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q1,Atrial fibrillation,,2015,Q1,6,F,20150216.0,20150310.0,20150302,20150330,EXP,,JP-JNJFOC-20150218136,JANSSEN,,65.0,YR,A,M,Y,68.0,KG,20150330.0,N,OT,JP,JP,2015,Q1,Elderly
108776426,10877642,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q1,Sinus node dysfunction,,2015,Q1,6,F,20150216.0,20150310.0,20150302,20150330,EXP,,JP-JNJFOC-20150218136,JANSSEN,,65.0,YR,A,M,Y,68.0,KG,20150330.0,N,OT,JP,JP,2015,Q1,Elderly
109282881,10928288,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,U,,,204042.0,100,DF,TABLET,QD,2015,Q1,Condition aggravated,,2015,Q1,1,I,20141106.0,20150310.0,20150319,20150319,EXP,,GB-JNJFOC-20150307825,JANSSEN,,45.0,YR,A,M,Y,,,20150319.0,N,MD,GB,GB,2015,Q1,Adult
109282881,10928288,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,U,,,204042.0,100,DF,TABLET,QD,2015,Q1,Hyperlipidaemia,,2015,Q1,1,I,20141106.0,20150310.0,20150319,20150319,EXP,,GB-JNJFOC-20150307825,JANSSEN,,45.0,YR,A,M,Y,,,20150319.0,N,MD,GB,GB,2015,Q1,Adult
109282881,10928288,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,U,,,204042.0,100,DF,TABLET,QD,2015,Q1,Hypertriglyceridaemia,,2015,Q1,1,I,20141106.0,20150310.0,20150319,20150319,EXP,,GB-JNJFOC-20150307825,JANSSEN,,45.0,YR,A,M,Y,,,20150319.0,N,MD,GB,GB,2015,Q1,Adult
109324361,10932436,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,ORAL,,,,D,D,,,,,,,QD,2015,Q1,Bronchitis,,2015,Q1,1,I,20150318.0,,20150319,20150319,DIR,,,,,40.0,YR,,F,N,,,20150318.0,Y,MD,US,,2015,Q1,Adult
109324361,10932436,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,ORAL,,,,D,D,,,,,,,QD,2015,Q1,Diabetic ketoacidosis,,2015,Q1,1,I,20150318.0,,20150319,20150319,DIR,,,,,40.0,YR,,F,N,,,20150318.0,Y,MD,US,,2015,Q1,Adult
109324361,10932436,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,ORAL,,,,D,D,,,,,,,QD,2015,Q1,Myalgia,,2015,Q1,1,I,20150318.0,,20150319,20150319,DIR,,,,,40.0,YR,,F,N,,,20150318.0,Y,MD,US,,2015,Q1,Adult
109324361,10932436,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,ORAL,,,,D,D,,,,,,,QD,2015,Q1,Nausea,,2015,Q1,1,I,20150318.0,,20150319,20150319,DIR,,,,,40.0,YR,,F,N,,,20150318.0,Y,MD,US,,2015,Q1,Adult
109324361,10932436,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,ORAL,,,,D,D,,,,,,,QD,2015,Q1,Off label use,,2015,Q1,1,I,20150318.0,,20150319,20150319,DIR,,,,,40.0,YR,,F,N,,,20150318.0,Y,MD,US,,2015,Q1,Adult
109324361,10932436,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,ORAL,,,,D,D,,,,,,,QD,2015,Q1,Pneumonia,,2015,Q1,1,I,20150318.0,,20150319,20150319,DIR,,,,,40.0,YR,,F,N,,,20150318.0,Y,MD,US,,2015,Q1,Adult
109655631,10965563,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,U,,,204042.0,100,MG,TABLET,QD,2015,Q1,Gastritis,,2015,Q1,1,I,20141212.0,20150320.0,20150330,20150330,EXP,,GB-JNJFOC-20150316287,JANSSEN,,60.0,YR,A,M,Y,93.8,KG,20150330.0,N,MD,GB,GB,2015,Q1,Adult
109655631,10965563,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,U,,,204042.0,100,MG,TABLET,QD,2015,Q1,Jaundice,,2015,Q1,1,I,20141212.0,20150320.0,20150330,20150330,EXP,,GB-JNJFOC-20150316287,JANSSEN,,60.0,YR,A,M,Y,93.8,KG,20150330.0,N,MD,GB,GB,2015,Q1,Adult
109655631,10965563,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,U,,,204042.0,100,MG,TABLET,QD,2015,Q1,Pancreatic disorder,,2015,Q1,1,I,20141212.0,20150320.0,20150330,20150330,EXP,,GB-JNJFOC-20150316287,JANSSEN,,60.0,YR,A,M,Y,93.8,KG,20150330.0,N,MD,GB,GB,2015,Q1,Adult
109661151,10966115,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,1 TABLET BEFORE BREAKFAST WITH WATER,,,,N, UNKNOWN,,204042.0,100,MG,TABLET,,2015,Q1,Influenza,,2015,Q1,1,I,20150104.0,20150105.0,20150330,20150330,EXP,,JP-JNJFOC-20150114101,JANSSEN,,68.0,YR,E,M,Y,55.0,KG,20150330.0,N,OT,JP,JP,2015,Q1,Elderly
109661151,10966115,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,1 TABLET BEFORE BREAKFAST WITH WATER,,,,N, UNKNOWN,,204042.0,100,MG,TABLET,,2015,Q1,Pneumonia,,2015,Q1,1,I,20150104.0,20150105.0,20150330,20150330,EXP,,JP-JNJFOC-20150114101,JANSSEN,,68.0,YR,E,M,Y,55.0,KG,20150330.0,N,OT,JP,JP,2015,Q1,Elderly
109694451,10969445,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,100,MG,TABLET,QD,2015,Q1,Acidosis,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,100,MG,TABLET,QD,2015,Q1,Dehydration,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,100,MG,TABLET,QD,2015,Q1,Gastroenteritis,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,100,MG,TABLET,QD,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,100,MG,TABLET,QD,2015,Q1,Renal impairment,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,300,MG,TABLET,QD,2015,Q1,Acidosis,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,300,MG,TABLET,QD,2015,Q1,Dehydration,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,300,MG,TABLET,QD,2015,Q1,Gastroenteritis,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,300,MG,TABLET,QD,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,,300,MG,TABLET,QD,2015,Q1,Renal impairment,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,,,TABLET,,2015,Q1,Acidosis,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,,,TABLET,,2015,Q1,Dehydration,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,,,TABLET,,2015,Q1,Gastroenteritis,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,,,TABLET,,2015,Q1,Hyperglycaemia,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
109694451,10969445,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,,,TABLET,,2015,Q1,Renal impairment,,2015,Q1,1,I,,20150218.0,20150331,20150331,EXP,,US-JNJFOC-20150221479,JANSSEN,OKISUGI M. A CASE OF SEVERE DEHYDRATION DUE TO GASTROENTERITIS DURING CANAGLIFLOZIN ADMINISTRATION.. THE 52TH ANNUAL MEETING OF KANTOUKOUSHINETSU REGION OF THE JAPAN DIABETES SOCIETY 2015;65: .,66.0,YR,E,M,Y,,,20150331.0,N,OT,US,US,2015,Q1,Elderly
92044497,9204449,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,204042.0,,,CAPSULE,,2015,Q1,Metastatic renal cell carcinoma,,2015,Q1,7,F,20130308.0,20150113.0,20130402,20150120,EXP,,AU-JNJFOC-20130308443,JANSSEN,,62.0,YR,A,M,Y,104.4,KG,20150119.0,N,MD,AU,AU,2015,Q1,Adult
92044497,9204449,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,ORAL,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q1,Metastatic renal cell carcinoma,,2015,Q1,7,F,20130308.0,20150113.0,20130402,20150120,EXP,,AU-JNJFOC-20130308443,JANSSEN,,62.0,YR,A,M,Y,104.4,KG,20150119.0,N,MD,AU,AU,2015,Q1,Adult
104250124,10425012,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q2,Contusion,,2015,Q2,4,F,2014.0,20150331.0,20140902,20150406,EXP,,AU-SA-2014SA115997,AVENTIS,,62.0,YR,A,F,Y,,,20150406.0,N,CN,AU,AU,2015,Q2,Adult
104250124,10425012,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q2,Diarrhoea,,2015,Q2,4,F,2014.0,20150331.0,20140902,20150406,EXP,,AU-SA-2014SA115997,AVENTIS,,62.0,YR,A,F,Y,,,20150406.0,N,CN,AU,AU,2015,Q2,Adult
104250124,10425012,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q2,Hypertension,,2015,Q2,4,F,2014.0,20150331.0,20140902,20150406,EXP,,AU-SA-2014SA115997,AVENTIS,,62.0,YR,A,F,Y,,,20150406.0,N,CN,AU,AU,2015,Q2,Adult
104250124,10425012,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q2,Loss of consciousness,,2015,Q2,4,F,2014.0,20150331.0,20140902,20150406,EXP,,AU-SA-2014SA115997,AVENTIS,,62.0,YR,A,F,Y,,,20150406.0,N,CN,AU,AU,2015,Q2,Adult
104250124,10425012,10,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q2,Rash pruritic,,2015,Q2,4,F,2014.0,20150331.0,20140902,20150406,EXP,,AU-SA-2014SA115997,AVENTIS,,62.0,YR,A,F,Y,,,20150406.0,N,CN,AU,AU,2015,Q2,Adult
105690417,10569041,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4368704,,204042.0,,,CAPSULE,,2015,Q2,Myocardial ischaemia,,2015,Q2,7,F,20140916.0,20150408.0,20141106,20150417,EXP,,BE-JNJFOC-20141017691,JANSSEN,,55.0,YR,A,M,Y,99.0,KG,20150417.0,N,MD,BE,BE,2015,Q2,Adult
105690417,10569041,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4368704,,204042.0,,,CAPSULE,,2015,Q2,Scan myocardial perfusion abnormal,,2015,Q2,7,F,20140916.0,20150408.0,20141106,20150417,EXP,,BE-JNJFOC-20141017691,JANSSEN,,55.0,YR,A,M,Y,99.0,KG,20150417.0,N,MD,BE,BE,2015,Q2,Adult
105690417,10569041,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4368704,,76479.0,100,MG,CAPSULE,,2015,Q2,Myocardial ischaemia,,2015,Q2,7,F,20140916.0,20150408.0,20141106,20150417,EXP,,BE-JNJFOC-20141017691,JANSSEN,,55.0,YR,A,M,Y,99.0,KG,20150417.0,N,MD,BE,BE,2015,Q2,Adult
105690417,10569041,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4368704,,76479.0,100,MG,CAPSULE,,2015,Q2,Scan myocardial perfusion abnormal,,2015,Q2,7,F,20140916.0,20150408.0,20141106,20150417,EXP,,BE-JNJFOC-20141017691,JANSSEN,,55.0,YR,A,M,Y,99.0,KG,20150417.0,N,MD,BE,BE,2015,Q2,Adult
106572913,10657291,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042,,,CAPSULE,,2015,Q2,Gallbladder cancer,,2015,Q2,3,F,20140807.0,20150626.0,20141217,20150630,PER,,IN-JNJFOC-20140809587,JANSSEN,,55.0,YR,A,F,Y,61.3,KG,20150630.0,N,MD,IN,IN,2015,Q2,Adult
106572913,10657291,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042,,,CAPSULE,,2015,Q2,Hypoglycaemia,,2015,Q2,3,F,20140807.0,20150626.0,20141217,20150630,PER,,IN-JNJFOC-20140809587,JANSSEN,,55.0,YR,A,F,Y,61.3,KG,20150630.0,N,MD,IN,IN,2015,Q2,Adult
106572913,10657291,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,076479,300,MG,CAPSULE,QD,2015,Q2,Gallbladder cancer,,2015,Q2,3,F,20140807.0,20150626.0,20141217,20150630,PER,,IN-JNJFOC-20140809587,JANSSEN,,55.0,YR,A,F,Y,61.3,KG,20150630.0,N,MD,IN,IN,2015,Q2,Adult
106572913,10657291,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,076479,300,MG,CAPSULE,QD,2015,Q2,Hypoglycaemia,,2015,Q2,3,F,20140807.0,20150626.0,20141217,20150630,PER,,IN-JNJFOC-20140809587,JANSSEN,,55.0,YR,A,F,Y,61.3,KG,20150630.0,N,MD,IN,IN,2015,Q2,Adult
107972904,10797290,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q2,Influenza,,2015,Q2,4,F,20141226.0,20150424.0,20150216,20150508,EXP,,JP-JNJFOC-20150206459,JANSSEN,,59.0,YR,A,F,Y,67.0,KG,20150508.0,N,OT,JP,JP,2015,Q2,Adult
107972904,10797290,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q2,Ketoacidosis,,2015,Q2,4,F,20141226.0,20150424.0,20150216,20150508,EXP,,JP-JNJFOC-20150206459,JANSSEN,,59.0,YR,A,F,Y,67.0,KG,20150508.0,N,OT,JP,JP,2015,Q2,Adult
108736258,10873625,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST WITH WATER,,,,N, UNKNOWN,,204042.0,100,MG,TABLET,QD,2015,Q2,Cerebral infarction,,2015,Q2,8,F,20150210.0,20150612.0,20150227,20150624,EXP,,JP-JNJFOC-20150220081,JANSSEN,,70.0,YR,E,F,Y,53.0,KG,20150624.0,N,OT,JP,JP,2015,Q2,Elderly
109127333,10912733,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,100,MG,TABLET,,2015,Q2,Removal of internal fixation,,2015,Q2,3,F,20150226.0,20150406.0,20150313,20150421,PER,,JP-JNJFOC-20150305494,JANSSEN,,63.0,YR,A,M,Y,79.0,KG,20150421.0,N,OT,JP,JP,2015,Q2,Adult
109127333,10912733,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST,,,,N,,,204042.0,100,MG,TABLET,,2015,Q2,Removal of internal fixation,,2015,Q2,3,F,20150226.0,20150406.0,20150313,20150421,PER,,JP-JNJFOC-20150305494,JANSSEN,,63.0,YR,A,M,Y,79.0,KG,20150421.0,N,OT,JP,JP,2015,Q2,Adult
109393222,10939322,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,100,MG,CAPSULE,QD,2015,Q2,Pollakiuria,,2015,Q2,2,F,,20140303.0,20150322,20150524,PER,,US-JNJFOC-20140302290,JANSSEN,WYSHAM CH. THE US EXPERIENCE WITH CANAGLIFLOZIN: PRACTICAL MANAGEMENT OF PATIENTS. .,50.0,YR,A,M,Y,109.0,KG,20150524.0,N,OT,US,US,2015,Q2,Adult
109393242,10939324,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,N,,,204042.0,,,TABLET,,2015,Q2,Hyperkalaemia,,2015,Q2,2,F,,20140624.0,20150322,20150524,PER,,US-JNJFOC-20140617422,JANSSEN,"KITCHELL D, TSAI H, TSAI E. A SWEET RHYTHM. JOURNAL OF GENERAL INTERNAL MEDICINE 37TH ANNUAL MEETING OF THE SOCIETY OF GENERAL INTERNAL MEDICINE APR-2014;29:S287.",52.0,YR,A,M,Y,,,20150524.0,N,OT,GD,US,2015,Q2,Adult
109395592,10939559,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,TABLET,QD,2015,Q2,Hypoglycaemia,,2015,Q2,2,F,,20140303.0,20150322,20150524,PER,,US-JNJFOC-20140307486,JANSSEN,,58.0,YR,A,M,Y,147.0,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109395592,10939559,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,TABLET,QD,2015,Q2,Urine output increased,,2015,Q2,2,F,,20140303.0,20150322,20150524,PER,,US-JNJFOC-20140307486,JANSSEN,,58.0,YR,A,M,Y,147.0,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109395592,10939559,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,TABLET,QD,2015,Q2,Weight decreased,,2015,Q2,2,F,,20140303.0,20150322,20150524,PER,,US-JNJFOC-20140307486,JANSSEN,,58.0,YR,A,M,Y,147.0,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109395592,10939559,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,300,MG,TABLET,QD,2015,Q2,Hypoglycaemia,,2015,Q2,2,F,,20140303.0,20150322,20150524,PER,,US-JNJFOC-20140307486,JANSSEN,,58.0,YR,A,M,Y,147.0,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109395592,10939559,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,300,MG,TABLET,QD,2015,Q2,Urine output increased,,2015,Q2,2,F,,20140303.0,20150322,20150524,PER,,US-JNJFOC-20140307486,JANSSEN,,58.0,YR,A,M,Y,147.0,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109395592,10939559,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,300,MG,TABLET,QD,2015,Q2,Weight decreased,,2015,Q2,2,F,,20140303.0,20150322,20150524,PER,,US-JNJFOC-20140307486,JANSSEN,,58.0,YR,A,M,Y,147.0,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109404382,10940438,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,100,MG,TABLET,QD,2015,Q2,Blood creatinine increased,,2015,Q2,2,F,20130506.0,20130524.0,20150322,20150524,PER,,US-JNJFOC-20130504687,JANSSEN,,64.0,YR,A,M,Y,81.56,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109404382,10940438,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,100,MG,TABLET,QD,2015,Q2,Glomerular filtration rate decreased,,2015,Q2,2,F,20130506.0,20130524.0,20150322,20150524,PER,,US-JNJFOC-20130504687,JANSSEN,,64.0,YR,A,M,Y,81.56,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109404382,10940438,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,100,MG,TABLET,QD,2015,Q2,Hyperkalaemia,,2015,Q2,2,F,20130506.0,20130524.0,20150322,20150524,PER,,US-JNJFOC-20130504687,JANSSEN,,64.0,YR,A,M,Y,81.56,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109407392,10940739,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,CAPSULE,QD,2015,Q2,Acute kidney injury,,2015,Q2,2,F,,20140501.0,20150322,20150524,PER,,US-JNJFOC-20140501358,JANSSEN,"JAVAID M, GIORDANO J, TANENBERG RJ, ALHOSAINI H, HOUSTON CM. CANAGLIFLOZIN-ASSOCIATED ACUTE RENAL FAILURE IN A PATIENT WITH STAGE 2 CKD AND COMPENSATED HEART FAILURE. POSTER APR-2014.",38.0,YR,A,F,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109407392,10940739,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,CAPSULE,QD,2015,Q2,Hypovolaemia,,2015,Q2,2,F,,20140501.0,20150322,20150524,PER,,US-JNJFOC-20140501358,JANSSEN,"JAVAID M, GIORDANO J, TANENBERG RJ, ALHOSAINI H, HOUSTON CM. CANAGLIFLOZIN-ASSOCIATED ACUTE RENAL FAILURE IN A PATIENT WITH STAGE 2 CKD AND COMPENSATED HEART FAILURE. POSTER APR-2014.",38.0,YR,A,F,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109408302,10940830,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,EARLY NOVEMBER 2014,,,,U,,,204042.0,300,MG,TABLET,,2015,Q2,Pancreatitis,,2015,Q2,2,F,20141206.0,20150313.0,20150322,20150524,PER,,US-JNJFOC-20150311889,JANSSEN,,57.0,YR,A,M,Y,90.0,KG,20150524.0,N,PH,US,US,2015,Q2,Adult
109410332,10941033,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 13CG892,,,100,MG,TABLET,,2015,Q2,Nausea,,2015,Q2,2,F,2013.0,20130508.0,20150322,20150524,PER,,US-JNJFOC-20130505542,JANSSEN,,59.0,YR,A,M,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109410332,10941033,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 13CG892,,,100,MG,TABLET,,2015,Q2,Vomiting,,2015,Q2,2,F,2013.0,20130508.0,20150322,20150524,PER,,US-JNJFOC-20130505542,JANSSEN,,59.0,YR,A,M,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109410332,10941033,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 13CG892,,204042.0,300,MG,TABLET,QD,2015,Q2,Nausea,,2015,Q2,2,F,2013.0,20130508.0,20150322,20150524,PER,,US-JNJFOC-20130505542,JANSSEN,,59.0,YR,A,M,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109410332,10941033,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 13CG892,,204042.0,300,MG,TABLET,QD,2015,Q2,Vomiting,,2015,Q2,2,F,2013.0,20130508.0,20150322,20150524,PER,,US-JNJFOC-20130505542,JANSSEN,,59.0,YR,A,M,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109413372,10941337,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,Y,,,204042.0,100,MG,CAPSULE,,2015,Q2,Flank pain,Flank pain,2015,Q2,2,F,,20130624.0,20150322,20150524,PER,,US-JNJFOC-20130616530,JANSSEN,,50.0,YR,A,M,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109416992,10941699,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300,MG,CAPSULE,QD,2015,Q2,Glomerular filtration rate decreased,,2015,Q2,2,F,,20140912.0,20150322,20150524,PER,,US-JNJFOC-20140907119,JANSSEN,,72.0,YR,E,M,Y,,,20150524.0,N,MD,US,US,2015,Q2,Elderly
109416992,10941699,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,CAPSULE,QD,2015,Q2,Glomerular filtration rate decreased,,2015,Q2,2,F,,20140912.0,20150322,20150524,PER,,US-JNJFOC-20140907119,JANSSEN,,72.0,YR,E,M,Y,,,20150524.0,N,MD,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Abdominal discomfort,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Bladder repair,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Chest discomfort,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Chest pain,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Cystitis,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Decreased appetite,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Diarrhoea,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Dizziness,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Dysphonia,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Dyspnoea exertional,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Faeces discoloured,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Fatigue,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Heart rate abnormal,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Nausea,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Palpitations,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Productive cough,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Pyrexia,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Rhinorrhoea,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
109750573,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q2,Vomiting,,2015,Q2,3,F,,20150608.0,20150401,20150618,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20150619.0,N,OT,US,US,2015,Q2,Elderly
110085081,11008508,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300,MG,,QD,2015,Q2,Acute kidney injury,,2015,Q2,1,I,20150402.0,,20150409,20150409,DIR,,,,,72.0,YR,,F,N,42.0,KG,20150408.0,N,PH,US,,2015,Q2,Elderly
110085081,11008508,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300,MG,,QD,2015,Q2,Asthenia,,2015,Q2,1,I,20150402.0,,20150409,20150409,DIR,,,,,72.0,YR,,F,N,42.0,KG,20150408.0,N,PH,US,,2015,Q2,Elderly
110085081,11008508,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300,MG,,QD,2015,Q2,Decreased appetite,,2015,Q2,1,I,20150402.0,,20150409,20150409,DIR,,,,,72.0,YR,,F,N,42.0,KG,20150408.0,N,PH,US,,2015,Q2,Elderly
110085081,11008508,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300,MG,,QD,2015,Q2,Hyperkalaemia,,2015,Q2,1,I,20150402.0,,20150409,20150409,DIR,,,,,72.0,YR,,F,N,42.0,KG,20150408.0,N,PH,US,,2015,Q2,Elderly
110085081,11008508,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300,MG,,QD,2015,Q2,Hypophagia,,2015,Q2,1,I,20150402.0,,20150409,20150409,DIR,,,,,72.0,YR,,F,N,42.0,KG,20150408.0,N,PH,US,,2015,Q2,Elderly
110085081,11008508,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300,MG,,QD,2015,Q2,Weight decreased,,2015,Q2,1,I,20150402.0,,20150409,20150409,DIR,,,,,72.0,YR,,F,N,42.0,KG,20150408.0,N,PH,US,,2015,Q2,Elderly
110247261,11024726,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q2,Fungal infection,,2015,Q2,1,I,20140626.0,,20150413,20150413,DIR,,,,,60.0,YR,,F,N,216.0,LBS,20150411.0,N,PH,US,,2015,Q2,Adult
110253484,11025348,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q2,Myocardial infarction,,2015,Q2,4,F,20150314.0,20150526.0,20150414,20150604,EXP,,JP-JNJFOC-20150408818,JANSSEN,,58.0,YR,A,M,Y,71.0,KG,20150604.0,N,OT,JP,JP,2015,Q2,Adult
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Asthenia,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Bronchitis,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Chills,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Dehydration,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Diverticulitis,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Dysuria,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Haematocrit decreased,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Haemoglobin decreased,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Hyperkalaemia,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Hypophagia,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Influenza like illness,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Nausea,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Pyrexia,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Red blood cell count decreased,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Vomiting,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110293911,11029391,7,C,Canagliflozin,CANAGLIFLOZIN,1,Oral,"1000 MG, BID",,,,D,,,,1000,MG,,,2015,Q2,Weight decreased,,2015,Q2,1,I,201503.0,20150320.0,20150415,20150415,EXP,,US-DENDREON CORPORATION-2015PROUSA04371,DENDREON,,66.0,YR,,M,Y,76.5,KG,20150415.0,N,MD,US,US,2015,Q2,Elderly
110380031,11038003,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,100.0,MG,,D,,,,100,MG,,QD,2015,Q2,Alopecia,,2015,Q2,1,I,20150306.0,20150408.0,20150416,20150416,EXP,,GB-ASTRAZENECA-2015SE33160,ASTRAZENECA,,51.0,YR,,M,Y,110.0,KG,20150416.0,N,MD,GB,GB,2015,Q2,Adult
110449601,11044960,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, UNKNOWN,,204042.0,,,CAPSULE,,2015,Q2,Acute respiratory failure,,2015,Q2,1,I,20150403.0,20150406.0,20150417,20150417,EXP,,US-JNJFOC-20150404978,JANSSEN,,67.0,YR,E,M,Y,113.0,KG,20150417.0,N,MD,US,US,2015,Q2,Elderly
110449601,11044960,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, UNKNOWN,,204042.0,,,CAPSULE,,2015,Q2,Escherichia sepsis,,2015,Q2,1,I,20150403.0,20150406.0,20150417,20150417,EXP,,US-JNJFOC-20150404978,JANSSEN,,67.0,YR,E,M,Y,113.0,KG,20150417.0,N,MD,US,US,2015,Q2,Elderly
110449601,11044960,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, UNKNOWN,,204042.0,,,CAPSULE,,2015,Q2,Urinary tract infection bacterial,,2015,Q2,1,I,20150403.0,20150406.0,20150417,20150417,EXP,,US-JNJFOC-20150404978,JANSSEN,,67.0,YR,E,M,Y,113.0,KG,20150417.0,N,MD,US,US,2015,Q2,Elderly
110449601,11044960,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, UNKNOWN,,76479.0,100,MG,CAPSULE,QD,2015,Q2,Acute respiratory failure,,2015,Q2,1,I,20150403.0,20150406.0,20150417,20150417,EXP,,US-JNJFOC-20150404978,JANSSEN,,67.0,YR,E,M,Y,113.0,KG,20150417.0,N,MD,US,US,2015,Q2,Elderly
110449601,11044960,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, UNKNOWN,,76479.0,100,MG,CAPSULE,QD,2015,Q2,Escherichia sepsis,,2015,Q2,1,I,20150403.0,20150406.0,20150417,20150417,EXP,,US-JNJFOC-20150404978,JANSSEN,,67.0,YR,E,M,Y,113.0,KG,20150417.0,N,MD,US,US,2015,Q2,Elderly
110449601,11044960,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, UNKNOWN,,76479.0,100,MG,CAPSULE,QD,2015,Q2,Urinary tract infection bacterial,,2015,Q2,1,I,20150403.0,20150406.0,20150417,20150417,EXP,,US-JNJFOC-20150404978,JANSSEN,,67.0,YR,E,M,Y,113.0,KG,20150417.0,N,MD,US,US,2015,Q2,Elderly
110567892,11056789,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,100,MG,TABLET,QD,2015,Q2,Ketoacidosis,,2015,Q2,2,F,20141201.0,20150313.0,20150422,20150524,PER,,US-JNJFOC-20150311914,JANSSEN,,57.0,YR,A,M,Y,101.15,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
110567892,11056789,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,,,TABLET,,2015,Q2,Ketoacidosis,,2015,Q2,2,F,20141201.0,20150313.0,20150422,20150524,PER,,US-JNJFOC-20150311914,JANSSEN,,57.0,YR,A,M,Y,101.15,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
110567892,11056789,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300,MG,TABLET,QD,2015,Q2,Ketoacidosis,,2015,Q2,2,F,20141201.0,20150313.0,20150422,20150524,PER,,US-JNJFOC-20150311914,JANSSEN,,57.0,YR,A,M,Y,101.15,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
110567892,11056789,4,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,,,TABLET,,2015,Q2,Ketoacidosis,,2015,Q2,2,F,20141201.0,20150313.0,20150422,20150524,PER,,US-JNJFOC-20150311914,JANSSEN,,57.0,YR,A,M,Y,101.15,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
110567892,11056789,5,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300,MG,TABLET,QD,2015,Q2,Ketoacidosis,,2015,Q2,2,F,20141201.0,20150313.0,20150422,20150524,PER,,US-JNJFOC-20150311914,JANSSEN,,57.0,YR,A,M,Y,101.15,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
110567892,11056789,6,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q2,Ketoacidosis,,2015,Q2,2,F,20141201.0,20150313.0,20150422,20150524,PER,,US-JNJFOC-20150311914,JANSSEN,,57.0,YR,A,M,Y,101.15,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
110582281,11058228,6,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,USE AS DIRECTED,,,,D,,,,,,,,2015,Q2,Skin ulcer,,2015,Q2,1,I,20150402.0,20150413.0,20150423,20150423,EXP,GB-MHRA-TPP8270615C95169YC1427984192626,GB-NOVOPROD-445887,NOVO NORDISK,,71.0,YR,E,M,Y,79.0,KG,20150423.0,N,MD,GB,GB,2015,Q2,Elderly
110619963,11061996,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 TABLET BEFORE BREAKFAST WITH WATER,,,,N, UNKNOWN,,204042.0,100,MG,TABLET,QD,2015,Q2,Acute myocardial infarction,,2015,Q2,3,F,20150410.0,20150604.0,20150424,20150618,EXP,,JP-JNJFOC-20150416109,JANSSEN,,66.0,YR,E,F,Y,62.0,KG,20150618.0,N,MD,JP,JP,2015,Q2,Elderly
110678702,11067870,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,100,MG,CAPSULE,,2015,Q2,Diarrhoea,,2015,Q2,2,F,20150407.0,20150424.0,20150427,20150504,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20150504.0,N,MD,US,US,2015,Q2,Adult
110678702,11067870,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,100,MG,CAPSULE,,2015,Q2,Fatigue,,2015,Q2,2,F,20150407.0,20150424.0,20150427,20150504,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20150504.0,N,MD,US,US,2015,Q2,Adult
110678702,11067870,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,300,MG,CAPSULE,QD,2015,Q2,Diarrhoea,,2015,Q2,2,F,20150407.0,20150424.0,20150427,20150504,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20150504.0,N,MD,US,US,2015,Q2,Adult
110678702,11067870,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,300,MG,CAPSULE,QD,2015,Q2,Fatigue,,2015,Q2,2,F,20150407.0,20150424.0,20150427,20150504,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20150504.0,N,MD,US,US,2015,Q2,Adult
110678702,11067870,3,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,DRUG START TIME: 07:13 HOURS??DRUG END TIME: 08:00 HOURS,,,,N, 14KG437,,204042.0,300,MG,CAPSULE,QD,2015,Q2,Diarrhoea,,2015,Q2,2,F,20150407.0,20150424.0,20150427,20150504,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20150504.0,N,MD,US,US,2015,Q2,Adult
110678702,11067870,3,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,DRUG START TIME: 07:13 HOURS??DRUG END TIME: 08:00 HOURS,,,,N, 14KG437,,204042.0,300,MG,CAPSULE,QD,2015,Q2,Fatigue,,2015,Q2,2,F,20150407.0,20150424.0,20150427,20150504,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20150504.0,N,MD,US,US,2015,Q2,Adult
110711103,11071110,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q2,Herpes zoster,,2015,Q2,3,F,20150410.0,20150508.0,20150428,20150515,PER,,JP-JNJFOC-20150419556,JANSSEN,,67.0,YR,E,M,Y,54.0,KG,20150515.0,N,OT,JP,JP,2015,Q2,Elderly
110771832,11077183,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,FOR 38 YEARS,,,,D,,,,,,UNSPECIFIED,,2015,Q2,Drug ineffective,,2015,Q2,2,F,,20140123.0,20150429,20150525,PER,,US-JNJFOC-20140116390,JANSSEN,,68.0,YR,E,F,Y,60.33,KG,20150525.0,N,CN,US,US,2015,Q2,Elderly
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Anion gap increased,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Blood ketone body increased,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Carbon dioxide abnormal,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Malaise,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Metabolic acidosis,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Procedural nausea,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Procedural pain,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908631,11090863,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1,,,D,D,,,,,,,QD,2015,Q2,Weight decreased,,2015,Q2,1,I,20150418.0,,20150504,20150504,DIR,,,,,64.0,YR,,F,N,,,20150503.0,Y,OT,US,,2015,Q2,Adult
110908681,11090868,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,ONE  QD ORAL,,,D,D,,,,,,,QD,2015,Q2,Asthenia,,2015,Q2,1,I,20150428.0,,20150504,20150504,DIR,,,,,38.0,YR,,M,N,410.0,LBS,20150503.0,Y,MD,US,,2015,Q2,Adult
110908681,11090868,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,ONE  QD ORAL,,,D,D,,,,,,,QD,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150428.0,,20150504,20150504,DIR,,,,,38.0,YR,,M,N,410.0,LBS,20150503.0,Y,MD,US,,2015,Q2,Adult
110908681,11090868,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,ONE  QD ORAL,,,D,D,,,,,,,QD,2015,Q2,Blood potassium decreased,,2015,Q2,1,I,20150428.0,,20150504,20150504,DIR,,,,,38.0,YR,,M,N,410.0,LBS,20150503.0,Y,MD,US,,2015,Q2,Adult
110908681,11090868,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,ONE  QD ORAL,,,D,D,,,,,,,QD,2015,Q2,Diabetic ketoacidosis,,2015,Q2,1,I,20150428.0,,20150504,20150504,DIR,,,,,38.0,YR,,M,N,410.0,LBS,20150503.0,Y,MD,US,,2015,Q2,Adult
110908681,11090868,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,ONE  QD ORAL,,,D,D,,,,,,,QD,2015,Q2,Dyspnoea,,2015,Q2,1,I,20150428.0,,20150504,20150504,DIR,,,,,38.0,YR,,M,N,410.0,LBS,20150503.0,Y,MD,US,,2015,Q2,Adult
110908681,11090868,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,ONE  QD ORAL,,,D,D,,,,,,,QD,2015,Q2,Metabolic acidosis,,2015,Q2,1,I,20150428.0,,20150504,20150504,DIR,,,,,38.0,YR,,M,N,410.0,LBS,20150503.0,Y,MD,US,,2015,Q2,Adult
110908681,11090868,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,ONE  QD ORAL,,,D,D,,,,,,,QD,2015,Q2,Weight decreased,,2015,Q2,1,I,20150428.0,,20150504,20150504,DIR,,,,,38.0,YR,,M,N,410.0,LBS,20150503.0,Y,MD,US,,2015,Q2,Adult
111125211,11112521,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 TABLET, BID, ORAL",,,N,N,,,,1,DF,TABLET,BID,2015,Q2,Bacteraemia,,2015,Q2,1,I,20150510.0,,20150513,20150513,DIR,,,,,47.0,YR,,M,N,91.7,KG,20150512.0,N,MD,US,,2015,Q2,Adult
111125211,11112521,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 TABLET, BID, ORAL",,,N,N,,,,1,DF,TABLET,BID,2015,Q2,Device related infection,,2015,Q2,1,I,20150510.0,,20150513,20150513,DIR,,,,,47.0,YR,,M,N,91.7,KG,20150512.0,N,MD,US,,2015,Q2,Adult
111125211,11112521,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 TABLET, BID, ORAL",,,N,N,,,,1,DF,TABLET,BID,2015,Q2,Glycosuria,,2015,Q2,1,I,20150510.0,,20150513,20150513,DIR,,,,,47.0,YR,,M,N,91.7,KG,20150512.0,N,MD,US,,2015,Q2,Adult
111125211,11112521,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 TABLET, BID, ORAL",,,N,N,,,,1,DF,TABLET,BID,2015,Q2,Post procedural infection,,2015,Q2,1,I,20150510.0,,20150513,20150513,DIR,,,,,47.0,YR,,M,N,91.7,KG,20150512.0,N,MD,US,,2015,Q2,Adult
111125211,11112521,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 TABLET, BID, ORAL",,,N,N,,,,1,DF,TABLET,BID,2015,Q2,Scrotal abscess,,2015,Q2,1,I,20150510.0,,20150513,20150513,DIR,,,,,47.0,YR,,M,N,91.7,KG,20150512.0,N,MD,US,,2015,Q2,Adult
111125211,11112521,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"1 TABLET, BID, ORAL",,,N,N,,,,1,DF,TABLET,BID,2015,Q2,Staphylococcal infection,,2015,Q2,1,I,20150510.0,,20150513,20150513,DIR,,,,,47.0,YR,,M,N,91.7,KG,20150512.0,N,MD,US,,2015,Q2,Adult
111150531,11115053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,TABLET,,2015,Q2,Sepsis,,2015,Q2,1,I,20150220.0,20150508.0,20150515,20150515,EXP,,GB-JNJFOC-20150505630,JANSSEN,,29.0,YR,A,F,Y,70.0,KG,20150515.0,N,MD,GB,GB,2015,Q2,Young Adult
111150531,11115053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,TABLET,,2015,Q2,Urinary tract infection,,2015,Q2,1,I,20150220.0,20150508.0,20150515,20150515,EXP,,GB-JNJFOC-20150505630,JANSSEN,,29.0,YR,A,F,Y,70.0,KG,20150515.0,N,MD,GB,GB,2015,Q2,Young Adult
111284751,11128475,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,N,Y,,,,100,MG,,QD,2015,Q2,Organising pneumonia,,2015,Q2,1,I,20141222.0,,20150520,20150520,DIR,,,,,62.0,YR,,M,N,127.0,KG,20150519.0,N,PH,US,,2015,Q2,Adult
111338231,11133823,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204042.0,100,MG,TABLET,QD,2015,Q2,Acute kidney injury,,2015,Q2,1,I,20141123.0,20150313.0,20150524,20150524,PER,,US-JNJFOC-20150311881,JANSSEN,,77.0,YR,E,F,Y,62.0,KG,20150524.0,N,PH,US,US,2015,Q2,Elderly
111338231,11133823,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204042.0,100,MG,TABLET,QD,2015,Q2,Pyelonephritis,,2015,Q2,1,I,20141123.0,20150313.0,20150524,20150524,PER,,US-JNJFOC-20150311881,JANSSEN,,77.0,YR,E,F,Y,62.0,KG,20150524.0,N,PH,US,US,2015,Q2,Elderly
111338231,11133823,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204042.0,100,MG,TABLET,QD,2015,Q2,Sepsis,,2015,Q2,1,I,20141123.0,20150313.0,20150524,20150524,PER,,US-JNJFOC-20150311881,JANSSEN,,77.0,YR,E,F,Y,62.0,KG,20150524.0,N,PH,US,US,2015,Q2,Elderly
111387581,11138758,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,1,DF,TABLET,QD,2015,Q2,Ketoacidosis,,2015,Q2,1,I,20150522.0,,20150526,20150526,DIR,,,,,47.0,YR,,F,N,77.0,KG,20150522.0,N,MD,US,,2015,Q2,Adult
111387581,11138758,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,1,DF,TABLET,QD,2015,Q2,Mental status changes,,2015,Q2,1,I,20150522.0,,20150526,20150526,DIR,,,,,47.0,YR,,F,N,77.0,KG,20150522.0,N,MD,US,,2015,Q2,Adult
111387581,11138758,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,1,DF,TABLET,QD,2015,Q2,Metabolic acidosis,,2015,Q2,1,I,20150522.0,,20150526,20150526,DIR,,,,,47.0,YR,,F,N,77.0,KG,20150522.0,N,MD,US,,2015,Q2,Adult
111479352,11147935,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, UIA,,204042.0,300,MG,TABLET,QD,2015,Q2,Ketoacidosis,,2015,Q2,2,F,20150125.0,20150617.0,20150529,20150629,PER,,US-JNJFOC-20150515643,JANSSEN,,63.0,YR,A,M,Y,,,20150629.0,N,CN,US,US,2015,Q2,Adult
111479352,11147935,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, UIA,,204042.0,300,MG,TABLET,QD,2015,Q2,Product use issue,,2015,Q2,2,F,20150125.0,20150617.0,20150529,20150629,PER,,US-JNJFOC-20150515643,JANSSEN,,63.0,YR,A,M,Y,,,20150629.0,N,CN,US,US,2015,Q2,Adult
111578891,11157889,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,CAPSULE,,2015,Q2,Bladder neoplasm,,2015,Q2,1,I,20150220.0,20150522.0,20150603,20150603,EXP,,AU-JNJFOC-20150516885,JANSSEN,,74.0,YR,E,M,Y,118.2,KG,20150603.0,N,MD,AU,AU,2015,Q2,Elderly
111578891,11157889,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,0.0,,,CAPSULE,,2015,Q2,Bladder neoplasm,,2015,Q2,1,I,20150220.0,20150522.0,20150603,20150603,EXP,,AU-JNJFOC-20150516885,JANSSEN,,74.0,YR,E,M,Y,118.2,KG,20150603.0,N,MD,AU,AU,2015,Q2,Elderly
111685151,11168515,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,204042.0,300,MG,CAPSULE,,2015,Q2,Headache,,2015,Q2,1,I,,20150522.0,20150605,20150605,EXP,,US-JNJFOC-20150604337,JANSSEN,"PETERS AL, BUSCHUR EO, BUSE JB, COHAN PC, DINER JC, HIRSCH IB. EUGLYCEMIC DIABETIC KETOACIDOSIS: A POTENTIAL COMPLICATION OF TREATMENT WITH SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITION  .",31.0,YR,A,F,Y,,,20150605.0,N,MD,US,US,2015,Q2,Young Adult
111685151,11168515,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,204042.0,300,MG,CAPSULE,,2015,Q2,Ketoacidosis,,2015,Q2,1,I,,20150522.0,20150605,20150605,EXP,,US-JNJFOC-20150604337,JANSSEN,"PETERS AL, BUSCHUR EO, BUSE JB, COHAN PC, DINER JC, HIRSCH IB. EUGLYCEMIC DIABETIC KETOACIDOSIS: A POTENTIAL COMPLICATION OF TREATMENT WITH SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITION  .",31.0,YR,A,F,Y,,,20150605.0,N,MD,US,US,2015,Q2,Young Adult
111769071,11176907,9,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q2,Diabetic ketoacidosis,,2015,Q2,1,I,20150602.0,,20150609,20150609,DIR,,,,,57.0,YR,,F,N,96.0,KG,20150608.0,N,PH,US,,2015,Q2,Adult
111879461,11187946,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,,,TABLET,,2015,Q2,Weight decreased,,2015,Q2,1,I,,20150505.0,20150615,20150615,PER,,US-JNJFOC-20150503407,JANSSEN,"LOTFI K, PALMER K, APOVIAN CM. CASE STUDY: WEIGHT LOSS IN A PATIENT WITH TYPE 2 DIABETES: CHALLENGES OF DIABETES MANAGEMENT. OBESITY APR-2015;23 (1):S11-S12.",63.0,YR,A,M,Y,112.95,KG,20150615.0,N,MD,US,US,2015,Q2,Adult
112001641,11200164,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, QD",,,,D,,,,100,MG,,QD,2015,Q2,Abdominal pain upper,,2015,Q2,1,I,,20150604.0,20150618,20150618,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-038077,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20150618.0,N,CN,DE,GB,2015,Q2,Elderly
112001641,11200164,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, QD",,,,D,,,,100,MG,,QD,2015,Q2,Pyrexia,,2015,Q2,1,I,,20150604.0,20150618,20150618,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-038077,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20150618.0,N,CN,DE,GB,2015,Q2,Elderly
112014581,11201458,5,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-DRREDDYS-GER/UKI/15/0048742,DR REDDYS,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112014581,11201458,5,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-DRREDDYS-GER/UKI/15/0048742,DR REDDYS,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112014581,11201458,5,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-DRREDDYS-GER/UKI/15/0048742,DR REDDYS,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112014581,11201458,5,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-DRREDDYS-GER/UKI/15/0048742,DR REDDYS,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112014581,11201458,5,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-DRREDDYS-GER/UKI/15/0048742,DR REDDYS,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112014581,11201458,5,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-DRREDDYS-GER/UKI/15/0048742,DR REDDYS,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112014581,11201458,5,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-DRREDDYS-GER/UKI/15/0048742,DR REDDYS,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112016081,11201608,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-MERCK-1506GBR008446,MERCK,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112016081,11201608,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-MERCK-1506GBR008446,MERCK,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112016081,11201608,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-MERCK-1506GBR008446,MERCK,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112016081,11201608,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-MERCK-1506GBR008446,MERCK,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112016081,11201608,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-MERCK-1506GBR008446,MERCK,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112016081,11201608,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-MERCK-1506GBR008446,MERCK,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112016081,11201608,7,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,,100,MG,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150619,20150619,EXP,GB-MHRA-EYC 00124277,GB-MERCK-1506GBR008446,MERCK,,77.0,YR,,M,Y,80.0,KG,20150619.0,N,CN,GB,GB,2015,Q2,Elderly
112016101,11201610,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100,MG,,QD,2015,Q2,Pruritus,,2015,Q2,1,I,20150106.0,,20150617,20150617,DIR,,,,,59.0,YR,,M,N,104.0,KG,20150316.0,N,PH,US,,2015,Q2,Adult
112016101,11201610,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,100,MG,,QD,2015,Q2,Urticaria,,2015,Q2,1,I,20150106.0,,20150617,20150617,DIR,,,,,59.0,YR,,M,N,104.0,KG,20150316.0,N,PH,US,,2015,Q2,Adult
112036302,11203630,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,CAPSULE,,2015,Q2,Prostate cancer,,2015,Q2,2,F,20150526.0,20150618.0,20150619,20150630,PER,,UA-JNJFOC-20150610510,JANSSEN,,62.0,YR,A,M,Y,87.0,KG,20150630.0,N,MD,UA,UA,2015,Q2,Adult
112036302,11203630,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,76479.0,100,MG,CAPSULE,,2015,Q2,Prostate cancer,,2015,Q2,2,F,20150526.0,20150618.0,20150619,20150630,PER,,UA-JNJFOC-20150610510,JANSSEN,,62.0,YR,A,M,Y,87.0,KG,20150630.0,N,MD,UA,UA,2015,Q2,Adult
112045771,11204577,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150622,20150622,EXP,GB-MHRA-EYC 00124277,GB-MICRO LABS LIMITED-BB2015-00638,MICRO LABS,,77.0,YR,,M,Y,80.0,KG,20150622.0,N,OT,GB,GB,2015,Q2,Elderly
112045771,11204577,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150622,20150622,EXP,GB-MHRA-EYC 00124277,GB-MICRO LABS LIMITED-BB2015-00638,MICRO LABS,,77.0,YR,,M,Y,80.0,KG,20150622.0,N,OT,GB,GB,2015,Q2,Elderly
112045771,11204577,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150622,20150622,EXP,GB-MHRA-EYC 00124277,GB-MICRO LABS LIMITED-BB2015-00638,MICRO LABS,,77.0,YR,,M,Y,80.0,KG,20150622.0,N,OT,GB,GB,2015,Q2,Elderly
112045771,11204577,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150622,20150622,EXP,GB-MHRA-EYC 00124277,GB-MICRO LABS LIMITED-BB2015-00638,MICRO LABS,,77.0,YR,,M,Y,80.0,KG,20150622.0,N,OT,GB,GB,2015,Q2,Elderly
112045771,11204577,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150622,20150622,EXP,GB-MHRA-EYC 00124277,GB-MICRO LABS LIMITED-BB2015-00638,MICRO LABS,,77.0,YR,,M,Y,80.0,KG,20150622.0,N,OT,GB,GB,2015,Q2,Elderly
112045771,11204577,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150622,20150622,EXP,GB-MHRA-EYC 00124277,GB-MICRO LABS LIMITED-BB2015-00638,MICRO LABS,,77.0,YR,,M,Y,80.0,KG,20150622.0,N,OT,GB,GB,2015,Q2,Elderly
112045771,11204577,6,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150622,20150622,EXP,GB-MHRA-EYC 00124277,GB-MICRO LABS LIMITED-BB2015-00638,MICRO LABS,,77.0,YR,,M,Y,80.0,KG,20150622.0,N,OT,GB,GB,2015,Q2,Elderly
112161261,11216126,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,N,D,,,,1,DF,TABLET,QD,2015,Q2,Acute kidney injury,,2015,Q2,1,I,20150606.0,,20150623,20150623,DIR,,,,,37.0,YR,,F,N,109.0,LBS,20150622.0,N,,US,,2015,Q2,Adult
112161261,11216126,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,N,D,,,,1,DF,TABLET,QD,2015,Q2,Anion gap,,2015,Q2,1,I,20150606.0,,20150623,20150623,DIR,,,,,37.0,YR,,F,N,109.0,LBS,20150622.0,N,,US,,2015,Q2,Adult
112161261,11216126,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,N,D,,,,1,DF,TABLET,QD,2015,Q2,Ketoacidosis,,2015,Q2,1,I,20150606.0,,20150623,20150623,DIR,,,,,37.0,YR,,F,N,109.0,LBS,20150622.0,N,,US,,2015,Q2,Adult
112161961,11216196,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q2,Drug ineffective,,2015,Q2,1,I,201505.0,20150619.0,20150624,20150624,PER,,US-BAYER-2015-362534,BAYER,,53.0,YR,A,M,Y,,,20150624.0,N,CN,US,US,2015,Q2,Adult
112162101,11216210,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150624,20150624,EXP,GB-MHRA-EYC 00124277,GB-TEVA-571889ACC,TEVA,,77.0,YR,,M,Y,80.0,KG,20150624.0,N,CN,GB,GB,2015,Q2,Elderly
112162101,11216210,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150624,20150624,EXP,GB-MHRA-EYC 00124277,GB-TEVA-571889ACC,TEVA,,77.0,YR,,M,Y,80.0,KG,20150624.0,N,CN,GB,GB,2015,Q2,Elderly
112162101,11216210,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150624,20150624,EXP,GB-MHRA-EYC 00124277,GB-TEVA-571889ACC,TEVA,,77.0,YR,,M,Y,80.0,KG,20150624.0,N,CN,GB,GB,2015,Q2,Elderly
112162101,11216210,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150624,20150624,EXP,GB-MHRA-EYC 00124277,GB-TEVA-571889ACC,TEVA,,77.0,YR,,M,Y,80.0,KG,20150624.0,N,CN,GB,GB,2015,Q2,Elderly
112162101,11216210,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150624,20150624,EXP,GB-MHRA-EYC 00124277,GB-TEVA-571889ACC,TEVA,,77.0,YR,,M,Y,80.0,KG,20150624.0,N,CN,GB,GB,2015,Q2,Elderly
112162101,11216210,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150624,20150624,EXP,GB-MHRA-EYC 00124277,GB-TEVA-571889ACC,TEVA,,77.0,YR,,M,Y,80.0,KG,20150624.0,N,CN,GB,GB,2015,Q2,Elderly
112162101,11216210,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150624,20150624,EXP,GB-MHRA-EYC 00124277,GB-TEVA-571889ACC,TEVA,,77.0,YR,,M,Y,80.0,KG,20150624.0,N,CN,GB,GB,2015,Q2,Elderly
112209591,11220959,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150626,20150626,EXP,GB-MHRA-EYC 00124277,GB-AUROBINDO-AUR-APL-2015-05292,AUROBINDO,,77.0,YR,,M,Y,80.0,KG,20150626.0,N,CN,GB,GB,2015,Q2,Elderly
112209591,11220959,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150626,20150626,EXP,GB-MHRA-EYC 00124277,GB-AUROBINDO-AUR-APL-2015-05292,AUROBINDO,,77.0,YR,,M,Y,80.0,KG,20150626.0,N,CN,GB,GB,2015,Q2,Elderly
112209591,11220959,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150626,20150626,EXP,GB-MHRA-EYC 00124277,GB-AUROBINDO-AUR-APL-2015-05292,AUROBINDO,,77.0,YR,,M,Y,80.0,KG,20150626.0,N,CN,GB,GB,2015,Q2,Elderly
112209591,11220959,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150626,20150626,EXP,GB-MHRA-EYC 00124277,GB-AUROBINDO-AUR-APL-2015-05292,AUROBINDO,,77.0,YR,,M,Y,80.0,KG,20150626.0,N,CN,GB,GB,2015,Q2,Elderly
112209591,11220959,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150626,20150626,EXP,GB-MHRA-EYC 00124277,GB-AUROBINDO-AUR-APL-2015-05292,AUROBINDO,,77.0,YR,,M,Y,80.0,KG,20150626.0,N,CN,GB,GB,2015,Q2,Elderly
112209591,11220959,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150626,20150626,EXP,GB-MHRA-EYC 00124277,GB-AUROBINDO-AUR-APL-2015-05292,AUROBINDO,,77.0,YR,,M,Y,80.0,KG,20150626.0,N,CN,GB,GB,2015,Q2,Elderly
112209591,11220959,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150626,20150626,EXP,GB-MHRA-EYC 00124277,GB-AUROBINDO-AUR-APL-2015-05292,AUROBINDO,,77.0,YR,,M,Y,80.0,KG,20150626.0,N,CN,GB,GB,2015,Q2,Elderly
112238791,11223879,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,GB-ACCORD-031565,ACCORD,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112238791,11223879,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,GB-ACCORD-031565,ACCORD,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112238791,11223879,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,GB-ACCORD-031565,ACCORD,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112238791,11223879,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,GB-ACCORD-031565,ACCORD,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112238791,11223879,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,GB-ACCORD-031565,ACCORD,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112238791,11223879,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,GB-ACCORD-031565,ACCORD,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112238791,11223879,8,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,GB-ACCORD-031565,ACCORD,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112241051,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112241051,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112241051,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112241051,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112241051,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112241051,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112241051,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20150629.0,N,CN,GB,GB,2015,Q2,Elderly
112251961,11225196,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,PHHY2015GB073019,SANDOZ,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,OT,GB,GB,2015,Q2,Elderly
112251961,11225196,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,PHHY2015GB073019,SANDOZ,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,OT,GB,GB,2015,Q2,Elderly
112251961,11225196,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,PHHY2015GB073019,SANDOZ,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,OT,GB,GB,2015,Q2,Elderly
112251961,11225196,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,PHHY2015GB073019,SANDOZ,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,OT,GB,GB,2015,Q2,Elderly
112251961,11225196,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,PHHY2015GB073019,SANDOZ,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,OT,GB,GB,2015,Q2,Elderly
112251961,11225196,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,PHHY2015GB073019,SANDOZ,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,OT,GB,GB,2015,Q2,Elderly
112251961,11225196,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100 MG,,,,D, EHZS000 07-2015,,,100,MG,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150629,20150629,EXP,GB-MHRA-EYC 00124277,PHHY2015GB073019,SANDOZ,,77.0,YR,,M,Y,80.0,KG,20150629.0,N,OT,GB,GB,2015,Q2,Elderly
112279681,11227968,4,I,Canagliflozin,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000,,,100,MG,,,2015,Q2,Amnesia,,2015,Q2,1,I,20150521.0,20150616.0,20150630,20150630,EXP,GB-MHRA-EYC 00124277,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003800,LUPIN,,77.0,YR,,M,Y,80.0,KG,20150630.0,N,,GB,GB,2015,Q2,Elderly
112279681,11227968,4,I,Canagliflozin,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000,,,100,MG,,,2015,Q2,Blood glucose increased,,2015,Q2,1,I,20150521.0,20150616.0,20150630,20150630,EXP,GB-MHRA-EYC 00124277,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003800,LUPIN,,77.0,YR,,M,Y,80.0,KG,20150630.0,N,,GB,GB,2015,Q2,Elderly
112279681,11227968,4,I,Canagliflozin,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000,,,100,MG,,,2015,Q2,Confusional state,,2015,Q2,1,I,20150521.0,20150616.0,20150630,20150630,EXP,GB-MHRA-EYC 00124277,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003800,LUPIN,,77.0,YR,,M,Y,80.0,KG,20150630.0,N,,GB,GB,2015,Q2,Elderly
112279681,11227968,4,I,Canagliflozin,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000,,,100,MG,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20150521.0,20150616.0,20150630,20150630,EXP,GB-MHRA-EYC 00124277,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003800,LUPIN,,77.0,YR,,M,Y,80.0,KG,20150630.0,N,,GB,GB,2015,Q2,Elderly
112279681,11227968,4,I,Canagliflozin,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000,,,100,MG,,,2015,Q2,Drug interaction,,2015,Q2,1,I,20150521.0,20150616.0,20150630,20150630,EXP,GB-MHRA-EYC 00124277,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003800,LUPIN,,77.0,YR,,M,Y,80.0,KG,20150630.0,N,,GB,GB,2015,Q2,Elderly
112279681,11227968,4,I,Canagliflozin,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000,,,100,MG,,,2015,Q2,Fasciitis,,2015,Q2,1,I,20150521.0,20150616.0,20150630,20150630,EXP,GB-MHRA-EYC 00124277,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003800,LUPIN,,77.0,YR,,M,Y,80.0,KG,20150630.0,N,,GB,GB,2015,Q2,Elderly
112279681,11227968,4,I,Canagliflozin,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000,,,100,MG,,,2015,Q2,Muscle spasms,,2015,Q2,1,I,20150521.0,20150616.0,20150630,20150630,EXP,GB-MHRA-EYC 00124277,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003800,LUPIN,,77.0,YR,,M,Y,80.0,KG,20150630.0,N,,GB,GB,2015,Q2,Elderly
112291681,11229168,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204042.0,100,MG,TABLET,,2015,Q2,Diabetic ketoacidosis,,2015,Q2,1,I,20140128.0,20150625.0,20150630,20150630,EXP,,US-JNJFOC-20150620478,JANSSEN,,37.0,YR,A,F,Y,74.39,KG,20150630.0,N,CN,US,US,2015,Q2,Adult
112291681,11229168,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, UNKNOWN,,204042.0,100,MG,TABLET,,2015,Q2,Product use issue,,2015,Q2,1,I,20140128.0,20150625.0,20150630,20150630,EXP,,US-JNJFOC-20150620478,JANSSEN,,37.0,YR,A,F,Y,74.39,KG,20150630.0,N,CN,US,US,2015,Q2,Adult
93001442,9300144,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,CAPSULE,QD,2015,Q2,Metastatic carcinoma of the bladder,,2015,Q2,2,F,20130115.0,20150410.0,20130521,20150417,EXP,,ES-JNJFOC-20130216730,JANSSEN,,71.0,YR,E,M,Y,77.3,KG,20150417.0,N,MD,ES,ES,2015,Q2,Elderly
93001442,9300144,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,76479.0,100,MG,CAPSULE,QD,2015,Q2,Metastatic carcinoma of the bladder,,2015,Q2,2,F,20130115.0,20150410.0,20130521,20150417,EXP,,ES-JNJFOC-20130216730,JANSSEN,,71.0,YR,E,M,Y,77.3,KG,20150417.0,N,MD,ES,ES,2015,Q2,Elderly
93074115,9307411,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 363427,,204042.0,,,CAPSULE,,2015,Q2,Bladder transitional cell carcinoma,,2015,Q2,5,F,20130514.0,20150430.0,20130524,20150515,EXP,,NZ-JNJFOC-20130510863,JANSSEN,,79.0,YR,E,M,Y,79.0,KG,20150515.0,N,MD,NZ,NZ,2015,Q2,Elderly
93074115,9307411,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 363427,,204042.0,,,CAPSULE,,2015,Q2,Transitional cell carcinoma,,2015,Q2,5,F,20130514.0,20150430.0,20130524,20150515,EXP,,NZ-JNJFOC-20130510863,JANSSEN,,79.0,YR,E,M,Y,79.0,KG,20150515.0,N,MD,NZ,NZ,2015,Q2,Elderly
93074115,9307411,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 363427,,76479.0,300,MG,CAPSULE,QD,2015,Q2,Bladder transitional cell carcinoma,,2015,Q2,5,F,20130514.0,20150430.0,20130524,20150515,EXP,,NZ-JNJFOC-20130510863,JANSSEN,,79.0,YR,E,M,Y,79.0,KG,20150515.0,N,MD,NZ,NZ,2015,Q2,Elderly
93074115,9307411,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 363427,,76479.0,300,MG,CAPSULE,QD,2015,Q2,Transitional cell carcinoma,,2015,Q2,5,F,20130514.0,20150430.0,20130524,20150515,EXP,,NZ-JNJFOC-20130510863,JANSSEN,,79.0,YR,E,M,Y,79.0,KG,20150515.0,N,MD,NZ,NZ,2015,Q2,Elderly
93807206,9380720,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B134502,,204042.0,,,CAPSULE,,2015,Q2,Transitional cell carcinoma,,2015,Q2,6,F,201206.0,20150511.0,20130702,20150522,EXP,,NL-JNJFOC-20130700097,JANSSEN,,64.0,YR,A,M,Y,85.1,KG,20150522.0,N,OT,NL,NL,2015,Q2,Adult
93807206,9380720,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B134502,,76479.0,300,MG,CAPSULE,QD,2015,Q2,Transitional cell carcinoma,,2015,Q2,6,F,201206.0,20150511.0,20130702,20150522,EXP,,NL-JNJFOC-20130700097,JANSSEN,,64.0,YR,A,M,Y,85.1,KG,20150522.0,N,OT,NL,NL,2015,Q2,Adult
102272347,10227234,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4367098,,204042.0,,,CAPSULE,,2015,Q3,Ketoacidosis,,2015,Q3,7,F,20140509.0,20150825.0,20140610,20150904,EXP,,UA-JNJFOC-20140511013,JANSSEN,"ERONDU N, DESAI M, WAYS K, MEININGER G. DIABETIC KETOACIDOSIS AND RELATED EVENTS IN THE CANAGLIFLOZIN TYPE 2 DIABETES CLINICAL PROGRAM. DIABETES CARE 2015;38:1680-1686.",62.0,YR,A,M,Y,88.6,KG,20150904.0,N,MD,UA,UA,2015,Q3,Adult
102272347,10227234,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4367098,,76479.0,300,MG,CAPSULE,QD,2015,Q3,Ketoacidosis,,2015,Q3,7,F,20140509.0,20150825.0,20140610,20150904,EXP,,UA-JNJFOC-20140511013,JANSSEN,"ERONDU N, DESAI M, WAYS K, MEININGER G. DIABETIC KETOACIDOSIS AND RELATED EVENTS IN THE CANAGLIFLOZIN TYPE 2 DIABETES CLINICAL PROGRAM. DIABETES CARE 2015;38:1680-1686.",62.0,YR,A,M,Y,88.6,KG,20150904.0,N,MD,UA,UA,2015,Q3,Adult
107972938,10797293,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3154684;3240665,,204042.0,,,CAPSULE,,2015,Q3,Neuroendocrine tumour,,2015,Q3,8,F,20150127.0,20150814.0,20150216,20150817,EXP,,AU-JNJFOC-20150203346,JANSSEN,,56.0,YR,A,M,Y,123.0,KG,20150817.0,N,MD,AU,AU,2015,Q3,Adult
107972938,10797293,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3154684;3240665,,76479.0,300,MG,CAPSULE,,2015,Q3,Neuroendocrine tumour,,2015,Q3,8,F,20150127.0,20150814.0,20150216,20150817,EXP,,AU-JNJFOC-20150203346,JANSSEN,,56.0,YR,A,M,Y,123.0,KG,20150817.0,N,MD,AU,AU,2015,Q3,Adult
108334417,10833441,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 43369273,,204042.0,,,CAPSULE,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,7,F,20150208.0,20150701.0,20150219,20150708,EXP,,US-JNJFOC-20150211927,JANSSEN,,44.0,YR,A,M,Y,141.0,KG,20150708.0,N,MD,US,US,2015,Q3,Adult
108334417,10833441,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,EVERY MORNING,,,,N, 43369273,,76479.0,300,MG,CAPSULE,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,7,F,20150208.0,20150701.0,20150219,20150708,EXP,,US-JNJFOC-20150211927,JANSSEN,,44.0,YR,A,M,Y,141.0,KG,20150708.0,N,MD,US,US,2015,Q3,Adult
108549883,10854988,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3546020;3053270,,204042.0,,,CAPSULE,,2015,Q3,Cardiac failure,,2015,Q3,3,F,20141124.0,20150714.0,20150223,20150717,EXP,,GB-JNJFOC-20150212082,JANSSEN,,79.0,YR,E,M,Y,65.9,KG,20150717.0,N,MD,GB,GB,2015,Q3,Elderly
108549883,10854988,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3546020;3053270,,204042.0,,,CAPSULE,,2015,Q3,Sepsis,,2015,Q3,3,F,20141124.0,20150714.0,20150223,20150717,EXP,,GB-JNJFOC-20150212082,JANSSEN,,79.0,YR,E,M,Y,65.9,KG,20150717.0,N,MD,GB,GB,2015,Q3,Elderly
108549883,10854988,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3546020;3053270,,76479.0,,,CAPSULE,,2015,Q3,Cardiac failure,,2015,Q3,3,F,20141124.0,20150714.0,20150223,20150717,EXP,,GB-JNJFOC-20150212082,JANSSEN,,79.0,YR,E,M,Y,65.9,KG,20150717.0,N,MD,GB,GB,2015,Q3,Elderly
108549883,10854988,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3546020;3053270,,76479.0,,,CAPSULE,,2015,Q3,Sepsis,,2015,Q3,3,F,20141124.0,20150714.0,20150223,20150717,EXP,,GB-JNJFOC-20150212082,JANSSEN,,79.0,YR,E,M,Y,65.9,KG,20150717.0,N,MD,GB,GB,2015,Q3,Elderly
108776427,10877642,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q3,Atrial fibrillation,,2015,Q3,7,F,20150216.0,20150907.0,20150302,20150915,EXP,,JP-JNJFOC-20150218136,JANSSEN,,65.0,YR,A,M,Y,68.0,KG,20150915.0,N,OT,JP,JP,2015,Q3,Elderly
108776427,10877642,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q3,Sinus node dysfunction,,2015,Q3,7,F,20150216.0,20150907.0,20150302,20150915,EXP,,JP-JNJFOC-20150218136,JANSSEN,,65.0,YR,A,M,Y,68.0,KG,20150915.0,N,OT,JP,JP,2015,Q3,Elderly
109408314,10940831,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q3,Pancreatitis,,2015,Q3,4,F,20141215.0,20150602.0,20150322,20150812,PER,,US-JNJFOC-20150311890,JANSSEN,,61.0,YR,A,M,Y,103.0,KG,20150812.0,N,PH,US,US,2015,Q3,Adult
110556994,11055699,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4369229,,204042.0,,,CAPSULE,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,4,F,20150416.0,20150701.0,20150422,20150708,EXP,,CA-JNJFOC-20150417069,JANSSEN,,42.0,YR,A,F,Y,82.0,KG,20150708.0,N,MD,CA,CA,2015,Q3,Adult
110556994,11055699,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4369229,,76479.0,100,MG,CAPSULE,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,4,F,20150416.0,20150701.0,20150422,20150708,EXP,,CA-JNJFOC-20150417069,JANSSEN,,42.0,YR,A,F,Y,82.0,KG,20150708.0,N,MD,CA,CA,2015,Q3,Adult
110751905,11075190,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Blister,,2015,Q3,5,F,20150421.0,20150803.0,20150429,20150811,EXP,,US-BAYER-2015-165748,BAYER,,67.0,YR,E,F,Y,,,20150811.0,N,OT,US,US,2015,Q3,Elderly
110751905,11075190,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Drug interaction,,2015,Q3,5,F,20150421.0,20150803.0,20150429,20150811,EXP,,US-BAYER-2015-165748,BAYER,,67.0,YR,E,F,Y,,,20150811.0,N,OT,US,US,2015,Q3,Elderly
110751905,11075190,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Erythema,,2015,Q3,5,F,20150421.0,20150803.0,20150429,20150811,EXP,,US-BAYER-2015-165748,BAYER,,67.0,YR,E,F,Y,,,20150811.0,N,OT,US,US,2015,Q3,Elderly
110751905,11075190,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Gait disturbance,,2015,Q3,5,F,20150421.0,20150803.0,20150429,20150811,EXP,,US-BAYER-2015-165748,BAYER,,67.0,YR,E,F,Y,,,20150811.0,N,OT,US,US,2015,Q3,Elderly
110751905,11075190,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Malaise,,2015,Q3,5,F,20150421.0,20150803.0,20150429,20150811,EXP,,US-BAYER-2015-165748,BAYER,,67.0,YR,E,F,Y,,,20150811.0,N,OT,US,US,2015,Q3,Elderly
110751905,11075190,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Palmar-plantar erythrodysaesthesia syndrome,,2015,Q3,5,F,20150421.0,20150803.0,20150429,20150811,EXP,,US-BAYER-2015-165748,BAYER,,67.0,YR,E,F,Y,,,20150811.0,N,OT,US,US,2015,Q3,Elderly
110751905,11075190,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Therapeutic product ineffective,,2015,Q3,5,F,20150421.0,20150803.0,20150429,20150811,EXP,,US-BAYER-2015-165748,BAYER,,67.0,YR,E,F,Y,,,20150811.0,N,OT,US,US,2015,Q3,Elderly
110751905,11075190,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Therapy cessation,,2015,Q3,5,F,20150421.0,20150803.0,20150429,20150811,EXP,,US-BAYER-2015-165748,BAYER,,67.0,YR,E,F,Y,,,20150811.0,N,OT,US,US,2015,Q3,Elderly
111479383,11147938,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300,MG,TABLET,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300,MG,TABLET,,2015,Q3,Influenza like illness,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300,MG,TABLET,,2015,Q3,Pneumonia,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300,MG,TABLET,,2015,Q3,Product use issue,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300,MG,TABLET,,2015,Q3,Pulmonary embolism,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300,MG,TABLET,,2015,Q3,Diabetic ketoacidosis,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300,MG,TABLET,,2015,Q3,Influenza like illness,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300,MG,TABLET,,2015,Q3,Pneumonia,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300,MG,TABLET,,2015,Q3,Product use issue,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111479383,11147938,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300,MG,TABLET,,2015,Q3,Pulmonary embolism,,2015,Q3,3,F,20150214.0,20150818.0,20150529,20150825,PER,,CA-JNJFOC-20150514906,JANSSEN,,36.0,YR,A,M,Y,168.0,KG,20150825.0,N,MD,CA,CA,2015,Q3,Adult
111595153,11159515,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3250076;4368665,,204042.0,,,CAPSULE,,2015,Q3,Penile abscess,,2015,Q3,3,F,20150421.0,20150911.0,20150603,20150917,EXP,,ES-JNJFOC-20150513880,JANSSEN,,57.0,YR,A,M,Y,,,20150917.0,N,MD,ES,ES,2015,Q3,Adult
111595153,11159515,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3250076;4368665,,204042.0,,,CAPSULE,,2015,Q3,Penile prosthesis insertion,,2015,Q3,3,F,20150421.0,20150911.0,20150603,20150917,EXP,,ES-JNJFOC-20150513880,JANSSEN,,57.0,YR,A,M,Y,,,20150917.0,N,MD,ES,ES,2015,Q3,Adult
111595153,11159515,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3250076;4368665,,76479.0,300,MG,CAPSULE,,2015,Q3,Penile abscess,,2015,Q3,3,F,20150421.0,20150911.0,20150603,20150917,EXP,,ES-JNJFOC-20150513880,JANSSEN,,57.0,YR,A,M,Y,,,20150917.0,N,MD,ES,ES,2015,Q3,Adult
111595153,11159515,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 3250076;4368665,,76479.0,300,MG,CAPSULE,,2015,Q3,Penile prosthesis insertion,,2015,Q3,3,F,20150421.0,20150911.0,20150603,20150917,EXP,,ES-JNJFOC-20150513880,JANSSEN,,57.0,YR,A,M,Y,,,20150917.0,N,MD,ES,ES,2015,Q3,Adult
111840393,11184039,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 20083541,,204042.0,,,CAPSULE,,2015,Q3,Diabetes mellitus,,2015,Q3,3,F,20141022.0,20150618.0,20150612,20150702,EXP,,PL-JNJFOC-20141119306,JANSSEN,,60.0,YR,A,F,Y,135.0,KG,20150702.0,N,MD,PL,PL,2015,Q3,Adult
111840393,11184039,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 20083541,,,,,CAPSULE,,2015,Q3,Diabetes mellitus,,2015,Q3,3,F,20141022.0,20150618.0,20150612,20150702,EXP,,PL-JNJFOC-20141119306,JANSSEN,,60.0,YR,A,F,Y,135.0,KG,20150702.0,N,MD,PL,PL,2015,Q3,Adult
111887932,11188793,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,MG,TABLET,,2015,Q3,Hepatocellular carcinoma,,2015,Q3,2,F,20150318.0,20150728.0,20150615,20150805,EXP,,JP-JNJFOC-20150609098,JANSSEN,,61.0,YR,A,M,Y,75.0,KG,20150805.0,N,MD,JP,JP,2015,Q3,Adult
111910022,11191002,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, QD",,,,D,,,,100.0,MG,TABLET,QD,2015,Q3,Blood glucose increased,,2015,Q3,2,F,20150606.0,20150720.0,20150615,20150729,PER,,US-ELI_LILLY_AND_COMPANY-US201506004614,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20150729.0,N,MD,US,US,2015,Q3,Elderly
111910022,11191002,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, QD",,,,D,,,,100.0,MG,TABLET,QD,2015,Q3,Drug dose omission,,2015,Q3,2,F,20150606.0,20150720.0,20150615,20150729,PER,,US-ELI_LILLY_AND_COMPANY-US201506004614,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20150729.0,N,MD,US,US,2015,Q3,Elderly
111910022,11191002,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, QD",,,,D,,,,100.0,MG,TABLET,QD,2015,Q3,Hypothyroidism,,2015,Q3,2,F,20150606.0,20150720.0,20150615,20150729,PER,,US-ELI_LILLY_AND_COMPANY-US201506004614,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20150729.0,N,MD,US,US,2015,Q3,Elderly
112056743,11205674,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000 07-2015,,,100.0,MG,,,2015,Q3,Amnesia,,2015,Q3,3,F,20150521.0,20150616.0,20150622,20150701,EXP,GB-MHRA-EYC 00124277,GB-PFIZER INC-2015202627,PFIZER,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112056743,11205674,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000 07-2015,,,100.0,MG,,,2015,Q3,Blood glucose increased,,2015,Q3,3,F,20150521.0,20150616.0,20150622,20150701,EXP,GB-MHRA-EYC 00124277,GB-PFIZER INC-2015202627,PFIZER,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112056743,11205674,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000 07-2015,,,100.0,MG,,,2015,Q3,Confusional state,,2015,Q3,3,F,20150521.0,20150616.0,20150622,20150701,EXP,GB-MHRA-EYC 00124277,GB-PFIZER INC-2015202627,PFIZER,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112056743,11205674,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000 07-2015,,,100.0,MG,,,2015,Q3,Diabetes mellitus inadequate control,,2015,Q3,3,F,20150521.0,20150616.0,20150622,20150701,EXP,GB-MHRA-EYC 00124277,GB-PFIZER INC-2015202627,PFIZER,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112056743,11205674,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000 07-2015,,,100.0,MG,,,2015,Q3,Drug interaction,,2015,Q3,3,F,20150521.0,20150616.0,20150622,20150701,EXP,GB-MHRA-EYC 00124277,GB-PFIZER INC-2015202627,PFIZER,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112056743,11205674,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000 07-2015,,,100.0,MG,,,2015,Q3,Fasciitis,,2015,Q3,3,F,20150521.0,20150616.0,20150622,20150701,EXP,GB-MHRA-EYC 00124277,GB-PFIZER INC-2015202627,PFIZER,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112056743,11205674,7,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000 07-2015,,,100.0,MG,,,2015,Q3,Muscle spasms,,2015,Q3,3,F,20150521.0,20150616.0,20150622,20150701,EXP,GB-MHRA-EYC 00124277,GB-PFIZER INC-2015202627,PFIZER,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112157472,11215747,5,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2015,Q3,Diabetes mellitus inadequate control,,2015,Q3,2,F,,20150616.0,20150622,20150710,EXP,,2015GR_BP003646,GEDEON RICHTER,,77.0,YR,,M,N,80.0,KG,20150708.0,N,,GB,,2015,Q3,Elderly
112157472,11215747,5,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2015,Q3,Drug interaction,,2015,Q3,2,F,,20150616.0,20150622,20150710,EXP,,2015GR_BP003646,GEDEON RICHTER,,77.0,YR,,M,N,80.0,KG,20150708.0,N,,GB,,2015,Q3,Elderly
112235653,11223565,10,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000,,,100,MG,,,2015,Q3,Amnesia,,2015,Q3,3,F,20150521.0,20150623.0,20150628,20150825,EXP,GB-MHRA-EYC 00124277,GB-TAKEDA-2015TJP011506,TAKEDA,,77.0,YR,,M,Y,80.0,KG,20150825.0,N,OT,GB,GB,2015,Q3,Elderly
112235653,11223565,10,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000,,,100,MG,,,2015,Q3,Blood glucose increased,,2015,Q3,3,F,20150521.0,20150623.0,20150628,20150825,EXP,GB-MHRA-EYC 00124277,GB-TAKEDA-2015TJP011506,TAKEDA,,77.0,YR,,M,Y,80.0,KG,20150825.0,N,OT,GB,GB,2015,Q3,Elderly
112235653,11223565,10,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000,,,100,MG,,,2015,Q3,Confusional state,,2015,Q3,3,F,20150521.0,20150623.0,20150628,20150825,EXP,GB-MHRA-EYC 00124277,GB-TAKEDA-2015TJP011506,TAKEDA,,77.0,YR,,M,Y,80.0,KG,20150825.0,N,OT,GB,GB,2015,Q3,Elderly
112235653,11223565,10,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000,,,100,MG,,,2015,Q3,Diabetes mellitus inadequate control,,2015,Q3,3,F,20150521.0,20150623.0,20150628,20150825,EXP,GB-MHRA-EYC 00124277,GB-TAKEDA-2015TJP011506,TAKEDA,,77.0,YR,,M,Y,80.0,KG,20150825.0,N,OT,GB,GB,2015,Q3,Elderly
112235653,11223565,10,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000,,,100,MG,,,2015,Q3,Drug interaction,,2015,Q3,3,F,20150521.0,20150623.0,20150628,20150825,EXP,GB-MHRA-EYC 00124277,GB-TAKEDA-2015TJP011506,TAKEDA,,77.0,YR,,M,Y,80.0,KG,20150825.0,N,OT,GB,GB,2015,Q3,Elderly
112235653,11223565,10,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000,,,100,MG,,,2015,Q3,Fasciitis,,2015,Q3,3,F,20150521.0,20150623.0,20150628,20150825,EXP,GB-MHRA-EYC 00124277,GB-TAKEDA-2015TJP011506,TAKEDA,,77.0,YR,,M,Y,80.0,KG,20150825.0,N,OT,GB,GB,2015,Q3,Elderly
112235653,11223565,10,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D, EHZS000,,,100,MG,,,2015,Q3,Muscle spasms,,2015,Q3,3,F,20150521.0,20150623.0,20150628,20150825,EXP,GB-MHRA-EYC 00124277,GB-TAKEDA-2015TJP011506,TAKEDA,,77.0,YR,,M,Y,80.0,KG,20150825.0,N,OT,GB,GB,2015,Q3,Elderly
112274866,11227486,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q3,Cerebral infarction,,2015,Q3,6,F,20150617.0,20150723.0,20150630,20150731,EXP,,JP-JNJFOC-20150620341,JANSSEN,,58.0,YR,A,M,Y,79.0,KG,20150731.0,N,OT,JP,JP,2015,Q3,Adult
112299501,11229950,9,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D,,,,100,MG,,,2015,Q3,Amnesia,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,PER,,GB-ALVOGEN-2015AL002605,ALVOGEN,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,OT,GB,GB,2015,Q3,Elderly
112299501,11229950,9,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D,,,,100,MG,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,PER,,GB-ALVOGEN-2015AL002605,ALVOGEN,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,OT,GB,GB,2015,Q3,Elderly
112299501,11229950,9,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D,,,,100,MG,,,2015,Q3,Confusional state,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,PER,,GB-ALVOGEN-2015AL002605,ALVOGEN,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,OT,GB,GB,2015,Q3,Elderly
112299501,11229950,9,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D,,,,100,MG,,,2015,Q3,Diabetes mellitus inadequate control,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,PER,,GB-ALVOGEN-2015AL002605,ALVOGEN,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,OT,GB,GB,2015,Q3,Elderly
112299501,11229950,9,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D,,,,100,MG,,,2015,Q3,Drug interaction,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,PER,,GB-ALVOGEN-2015AL002605,ALVOGEN,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,OT,GB,GB,2015,Q3,Elderly
112299501,11229950,9,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D,,,,100,MG,,,2015,Q3,Fasciitis,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,PER,,GB-ALVOGEN-2015AL002605,ALVOGEN,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,OT,GB,GB,2015,Q3,Elderly
112299501,11229950,9,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,D,,,,100,MG,,,2015,Q3,Muscle spasms,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,PER,,GB-ALVOGEN-2015AL002605,ALVOGEN,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,OT,GB,GB,2015,Q3,Elderly
112305381,11230538,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q3,Amnesia,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,EXP,GB-MHRA-EYC 00124277,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-040164,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112305381,11230538,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,EXP,GB-MHRA-EYC 00124277,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-040164,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112305381,11230538,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q3,Confusional state,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,EXP,GB-MHRA-EYC 00124277,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-040164,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112305381,11230538,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q3,Diabetes mellitus inadequate control,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,EXP,GB-MHRA-EYC 00124277,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-040164,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112305381,11230538,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q3,Drug interaction,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,EXP,GB-MHRA-EYC 00124277,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-040164,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112305381,11230538,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q3,Fasciitis,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,EXP,GB-MHRA-EYC 00124277,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-040164,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112305381,11230538,4,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,,100,MG,,,2015,Q3,Muscle spasms,,2015,Q3,1,I,20150521.0,20150616.0,20150701,20150701,EXP,GB-MHRA-EYC 00124277,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-040164,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,80.0,KG,20150701.0,N,CN,GB,GB,2015,Q3,Elderly
112347852,11234785,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q3,Dizziness,,2015,Q3,2,F,201212.0,20150828.0,20150702,20150908,EXP,,US-NOVOPROD-454409,NOVO NORDISK,,59.0,YR,A,M,Y,140.59,KG,20150908.0,N,MD,US,US,2015,Q3,Adult
112347852,11234785,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q3,Gallbladder obstruction,,2015,Q3,2,F,201212.0,20150828.0,20150702,20150908,EXP,,US-NOVOPROD-454409,NOVO NORDISK,,59.0,YR,A,M,Y,140.59,KG,20150908.0,N,MD,US,US,2015,Q3,Adult
112347852,11234785,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q3,Off label use,,2015,Q3,2,F,201212.0,20150828.0,20150702,20150908,EXP,,US-NOVOPROD-454409,NOVO NORDISK,,59.0,YR,A,M,Y,140.59,KG,20150908.0,N,MD,US,US,2015,Q3,Adult
112347852,11234785,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q3,Pancreatitis,,2015,Q3,2,F,201212.0,20150828.0,20150702,20150908,EXP,,US-NOVOPROD-454409,NOVO NORDISK,,59.0,YR,A,M,Y,140.59,KG,20150908.0,N,MD,US,US,2015,Q3,Adult
112347852,11234785,18,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,UNK,,,,D,,,,,,,,2015,Q3,Tremor,,2015,Q3,2,F,201212.0,20150828.0,20150702,20150908,EXP,,US-NOVOPROD-454409,NOVO NORDISK,,59.0,YR,A,M,Y,140.59,KG,20150908.0,N,MD,US,US,2015,Q3,Adult
112365821,11236582,3,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,UNK,,,,U,,,,,,,,2015,Q3,Seizure,,2015,Q3,1,I,,20150409.0,20150702,20150702,PER,,US-TAKEDA-2015TUS004707,TAKEDA,,54.0,YR,,F,Y,,,20150703.0,N,CN,US,US,2015,Q3,Adult
112587141,11258714,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,Y,,,,100,MG,,QD,2015,Q3,Angioedema,,2015,Q3,1,I,20150413.0,,20150709,20150709,DIR,,,,,67.0,YR,,M,N,89.6,KG,20150618.0,N,PH,US,,2015,Q3,Elderly
112632793,11263279,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100,MG,TABLET,QD,2015,Q3,Gastric cancer,,2015,Q3,3,F,20150703.0,20150820.0,20150712,20150828,EXP,,JP-JNJFOC-20150707343,JANSSEN,,74.0,YR,E,M,Y,52.0,KG,20150828.0,N,OT,JP,JP,2015,Q3,Elderly
112655011,11265501,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL,,,D,N,,,,,,,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20150611.0,,20150710,20150710,DIR,,,,,28.0,YR,,M,N,95.4,KG,20150709.0,N,,COUNTRY NOT SPECIFIED,,2015,Q3,Young Adult
112655011,11265501,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL,,,D,N,,,,,,,QD,2015,Q3,Nausea,,2015,Q3,1,I,20150611.0,,20150710,20150710,DIR,,,,,28.0,YR,,M,N,95.4,KG,20150709.0,N,,COUNTRY NOT SPECIFIED,,2015,Q3,Young Adult
112655011,11265501,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL,,,D,N,,,,,,,QD,2015,Q3,Vomiting,,2015,Q3,1,I,20150611.0,,20150710,20150710,DIR,,,,,28.0,YR,,M,N,95.4,KG,20150709.0,N,,COUNTRY NOT SPECIFIED,,2015,Q3,Young Adult
112655541,11265554,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,N,,,,1,DF,,QD,2015,Q3,Asthenia,,2015,Q3,1,I,20150616.0,,20150710,20150710,DIR,,,,,56.0,YR,,M,N,93.9,KG,20150709.0,N,OT,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
112655541,11265554,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,N,,,,1,DF,,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20150616.0,,20150710,20150710,DIR,,,,,56.0,YR,,M,N,93.9,KG,20150709.0,N,OT,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
112655541,11265554,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,N,,,,1,DF,,QD,2015,Q3,Nausea,,2015,Q3,1,I,20150616.0,,20150710,20150710,DIR,,,,,56.0,YR,,M,N,93.9,KG,20150709.0,N,OT,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
112655541,11265554,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,N,,,,1,DF,,QD,2015,Q3,Vomiting,,2015,Q3,1,I,20150616.0,,20150710,20150710,DIR,,,,,56.0,YR,,M,N,93.9,KG,20150709.0,N,OT,COUNTRY NOT SPECIFIED,,2015,Q3,Adult
112695192,11269519,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, T195186,,204042.0,,,CAPSULE,,2015,Q3,Encephalopathy,,2015,Q3,2,F,20150620.0,20150913.0,20150714,20150916,EXP,,US-JNJFOC-20150619143,JANSSEN,,80.0,YR,E,M,Y,145.6,KG,20150916.0,N,MD,US,US,2015,Q3,Elderly
112695192,11269519,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, T195186,,204042.0,,,CAPSULE,,2015,Q3,Respiratory failure,,2015,Q3,2,F,20150620.0,20150913.0,20150714,20150916,EXP,,US-JNJFOC-20150619143,JANSSEN,,80.0,YR,E,M,Y,145.6,KG,20150916.0,N,MD,US,US,2015,Q3,Elderly
112695192,11269519,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, T195186,,76479.0,,,CAPSULE,,2015,Q3,Encephalopathy,,2015,Q3,2,F,20150620.0,20150913.0,20150714,20150916,EXP,,US-JNJFOC-20150619143,JANSSEN,,80.0,YR,E,M,Y,145.6,KG,20150916.0,N,MD,US,US,2015,Q3,Elderly
112695192,11269519,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, T195186,,76479.0,,,CAPSULE,,2015,Q3,Respiratory failure,,2015,Q3,2,F,20150620.0,20150913.0,20150714,20150916,EXP,,US-JNJFOC-20150619143,JANSSEN,,80.0,YR,E,M,Y,145.6,KG,20150916.0,N,MD,US,US,2015,Q3,Elderly
112788011,11278801,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,TABLET,,2015,Q3,Glucose urine present,,2015,Q3,1,I,20150418.0,20150710.0,20150717,20150717,EXP,,GB-JNJFOC-20150707997,JANSSEN,,40.0,YR,A,F,Y,,,20150717.0,N,MD,GB,GB,2015,Q3,Adult
112788011,11278801,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,TABLET,,2015,Q3,Pyrexia,,2015,Q3,1,I,20150418.0,20150710.0,20150717,20150717,EXP,,GB-JNJFOC-20150707997,JANSSEN,,40.0,YR,A,F,Y,,,20150717.0,N,MD,GB,GB,2015,Q3,Adult
112788011,11278801,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,TABLET,,2015,Q3,Urinary tract infection,,2015,Q3,1,I,20150418.0,20150710.0,20150717,20150717,EXP,,GB-JNJFOC-20150707997,JANSSEN,,40.0,YR,A,F,Y,,,20150717.0,N,MD,GB,GB,2015,Q3,Adult
112788011,11278801,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,TABLET,,2015,Q3,Urine ketone body present,,2015,Q3,1,I,20150418.0,20150710.0,20150717,20150717,EXP,,GB-JNJFOC-20150707997,JANSSEN,,40.0,YR,A,F,Y,,,20150717.0,N,MD,GB,GB,2015,Q3,Adult
112908781,11290878,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 TAB,,,,,,,,,,,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20150717.0,,20150720,20150720,DIR,,,,,46.0,YR,,F,N,74.8,KG,20150717.0,N,MD,US,,2015,Q3,Adult
112908781,11290878,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 TAB,,,,,,,,,,,QD,2015,Q3,Impaired gastric emptying,,2015,Q3,1,I,20150717.0,,20150720,20150720,DIR,,,,,46.0,YR,,F,N,74.8,KG,20150717.0,N,MD,US,,2015,Q3,Adult
112939391,11293939,3,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Eructation,,2015,Q3,1,I,201506.0,20150703.0,20150722,20150722,EXP,,US-GLAXOSMITHKLINE-US2015GSK097581,GLAXOSMITHKLINE,,60.0,YR,,F,Y,,,20150722.0,N,CN,US,US,2015,Q3,Adult
113115001,11311500,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,MG,TABLET,,2015,Q3,Organising pneumonia,,2015,Q3,1,I,201502.0,20150713.0,20150727,20150727,EXP,,US-JNJFOC-20150709601,JANSSEN,,62.0,YR,A,M,Y,127.0,KG,20150727.0,N,PH,US,US,2015,Q3,Adult
113217642,11321764,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N,,,204042.0,,,TABLET,,2015,Q3,Pancreatitis acute,,2015,Q3,2,F,,20150803.0,20150729,20150810,EXP,,US-JNJFOC-20150717501,JANSSEN,"CHOWDHARY M, KABBANI AA, CHHABRA A. CANAGLIFLOZIN-INDUCED PANCREATITIS: A RARE SIDE EFFECT OF A NEW DRUG. THERAPEUTICS AND CLINICAL RISK MANAGEMENT 26-JUN-2015;11:991-994.",33.0,YR,A,F,Y,,,20150810.0,N,OT,US,US,2015,Q3,Young Adult
113265051,11326505,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, UNSURE,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20150713.0,20150729.0,20150731,20150731,EXP,,GB-JNJFOC-20150721642,JANSSEN,,67.0,YR,E,M,Y,141.0,KG,20150731.0,N,MD,GB,GB,2015,Q3,Elderly
113265061,11326506,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Large intestine polyp,,2015,Q3,1,I,20150721.0,20150723.0,20150731,20150731,EXP,,JP-JNJFOC-20150722750,JANSSEN,,71.0,YR,E,M,Y,68.0,KG,20150731.0,N,OT,JP,JP,2015,Q3,Elderly
113360651,11336065,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,D,,,,,,,,2015,Q3,Pancreatitis acute,,2015,Q3,1,I,,20150721.0,20150804,20150804,EXP,,PHHY2015US090513,SANDOZ,"CHOWDHARY M, KABBANI AA, CHHABRA A. CANAGLIFLOZIN-INDUCED PANCREATITIS: A RARE SIDE EFFECT OF A NEW DRUG. THERAPEUTICS AND CLINICAL RISK MANAGEMENT. 2015;11:991-4",33.0,YR,,F,Y,,,20150804.0,N,OT,US,US,2015,Q3,Young Adult
113402421,11340242,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,1.0,DF,,QD,2015,Q3,Ketoacidosis,,2015,Q3,1,I,20150730.0,,20150803,20150803,DIR,,,,,40.0,YR,,M,N,240.0,LBS,20150731.0,N,PH,US,,2015,Q3,Adult
113402421,11340242,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,1.0,DF,,QD,2015,Q3,Tachycardia,,2015,Q3,1,I,20150730.0,,20150803,20150803,DIR,,,,,40.0,YR,,M,N,240.0,LBS,20150731.0,N,PH,US,,2015,Q3,Adult
113408972,11340897,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100.0,MG,CAPSULE,QD,2015,Q3,Chondrocalcinosis pyrophosphate,,2015,Q3,2,F,20150726.0,20150808.0,20150805,20150817,PER,,JP-JNJFOC-20150800802,JANSSEN,,73.0,YR,E,F,Y,54.0,KG,20150817.0,N,OT,JP,JP,2015,Q3,Elderly
113451461,11345146,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, QD",16300.0,MG,,D,,,,100.0,MG,TABLET,QD,2015,Q3,Acute myocardial infarction,,2015,Q3,1,I,20150531.0,20150723.0,20150806,20150806,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051316,BRISTOL MYERS SQUIBB,,45.0,YR,,M,Y,105.0,KG,20150806.0,N,CN,DE,JP,2015,Q3,Adult
113451461,11345146,6,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, QD",16300.0,MG,,D,,,,100.0,MG,TABLET,QD,2015,Q3,Cardiac failure,,2015,Q3,1,I,20150531.0,20150723.0,20150806,20150806,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-051316,BRISTOL MYERS SQUIBB,,45.0,YR,,M,Y,105.0,KG,20150806.0,N,CN,DE,JP,2015,Q3,Adult
113497811,11349781,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, FCZS300,,204042.0,100.0,MG,TABLET,,2015,Q3,Asthenia,,2015,Q3,1,I,201505.0,20150729.0,20150807,20150807,EXP,,GB-JNJFOC-20150721532,JANSSEN,,75.0,YR,E,M,Y,79.37,KG,20150807.0,N,CN,GB,GB,2015,Q3,Elderly
113497811,11349781,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, FCZS300,,204042.0,100.0,MG,TABLET,,2015,Q3,Dizziness,,2015,Q3,1,I,201505.0,20150729.0,20150807,20150807,EXP,,GB-JNJFOC-20150721532,JANSSEN,,75.0,YR,E,M,Y,79.37,KG,20150807.0,N,CN,GB,GB,2015,Q3,Elderly
113497811,11349781,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, FCZS300,,204042.0,100.0,MG,TABLET,,2015,Q3,Fatigue,,2015,Q3,1,I,201505.0,20150729.0,20150807,20150807,EXP,,GB-JNJFOC-20150721532,JANSSEN,,75.0,YR,E,M,Y,79.37,KG,20150807.0,N,CN,GB,GB,2015,Q3,Elderly
113497811,11349781,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, FCZS300,,204042.0,100.0,MG,TABLET,,2015,Q3,Pruritus genital,,2015,Q3,1,I,201505.0,20150729.0,20150807,20150807,EXP,,GB-JNJFOC-20150721532,JANSSEN,,75.0,YR,E,M,Y,79.37,KG,20150807.0,N,CN,GB,GB,2015,Q3,Elderly
113497811,11349781,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, FCZS300,,204042.0,100.0,MG,TABLET,,2015,Q3,Thirst,,2015,Q3,1,I,201505.0,20150729.0,20150807,20150807,EXP,,GB-JNJFOC-20150721532,JANSSEN,,75.0,YR,E,M,Y,79.37,KG,20150807.0,N,CN,GB,GB,2015,Q3,Elderly
113497832,11349783,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,CAPSULE,,2015,Q3,Ketosis,,2015,Q3,2,F,20150726.0,20150825.0,20150807,20150902,PER,,AU-JNJFOC-20150721226,JANSSEN,,82.0,YR,E,F,Y,64.0,KG,20150902.0,N,MD,AU,AU,2015,Q3,Elderly
113497832,11349783,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,76479.0,,,CAPSULE,,2015,Q3,Ketosis,,2015,Q3,2,F,20150726.0,20150825.0,20150807,20150902,PER,,AU-JNJFOC-20150721226,JANSSEN,,82.0,YR,E,F,Y,64.0,KG,20150902.0,N,MD,AU,AU,2015,Q3,Elderly
113497841,11349784,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N,,,204042.0,,,TABLET,,2015,Q3,Hypercalcaemia,,2015,Q3,1,I,,20150728.0,20150807,20150807,EXP,,US-JNJFOC-20150722668,JANSSEN,"KAUR A. SEVERE HYPERCALCEMIA AND HYPERNATREMIA IN A PATIENT TREATED WITH CANAGLIFLOZIN. ENDOCRINOLOGY, DIABETES AND METABOLISM CASE REPORTS JUL-2015.",60.0,YR,A,M,Y,,,20150807.0,N,OT,US,US,2015,Q3,Adult
113525501,11352550,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,D,,,,,,TABLET,,2015,Q3,Drug ineffective for unapproved indication,,2015,Q3,1,I,,20150303.0,20150807,20150807,PER,,US-JNJFOC-20150304382,JANSSEN,,74.0,YR,E,F,Y,82.56,KG,20150807.0,N,CN,US,US,2015,Q3,Elderly
113525501,11352550,7,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,D,,,,,,TABLET,,2015,Q3,Product use issue,,2015,Q3,1,I,,20150303.0,20150807,20150807,PER,,US-JNJFOC-20150304382,JANSSEN,,74.0,YR,E,F,Y,82.56,KG,20150807.0,N,CN,US,US,2015,Q3,Elderly
113696421,11369642,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300.0,MG,TABLET,QD,2015,Q3,Intervertebral disc degeneration,,2015,Q3,1,I,20150408.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709616,JANSSEN,,64.0,YR,A,F,Y,,,20150812.0,N,MD,US,US,2015,Q3,Adult
113696421,11369642,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300.0,MG,TABLET,QD,2015,Q3,Metabolic acidosis,,2015,Q3,1,I,20150408.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709616,JANSSEN,,64.0,YR,A,F,Y,,,20150812.0,N,MD,US,US,2015,Q3,Adult
113696421,11369642,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300.0,MG,TABLET,QD,2015,Q3,Procedural pain,,2015,Q3,1,I,20150408.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709616,JANSSEN,,64.0,YR,A,F,Y,,,20150812.0,N,MD,US,US,2015,Q3,Adult
113696421,11369642,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,300.0,MG,TABLET,QD,2015,Q3,Weight decreased,,2015,Q3,1,I,20150408.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709616,JANSSEN,,64.0,YR,A,F,Y,,,20150812.0,N,MD,US,US,2015,Q3,Adult
113696421,11369642,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Intervertebral disc degeneration,,2015,Q3,1,I,20150408.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709616,JANSSEN,,64.0,YR,A,F,Y,,,20150812.0,N,MD,US,US,2015,Q3,Adult
113696421,11369642,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Metabolic acidosis,,2015,Q3,1,I,20150408.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709616,JANSSEN,,64.0,YR,A,F,Y,,,20150812.0,N,MD,US,US,2015,Q3,Adult
113696421,11369642,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Procedural pain,,2015,Q3,1,I,20150408.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709616,JANSSEN,,64.0,YR,A,F,Y,,,20150812.0,N,MD,US,US,2015,Q3,Adult
113696421,11369642,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Weight decreased,,2015,Q3,1,I,20150408.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709616,JANSSEN,,64.0,YR,A,F,Y,,,20150812.0,N,MD,US,US,2015,Q3,Adult
113700971,11370097,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,300.0,MG,TABLET,QD,2015,Q3,Bronchitis,,2015,Q3,1,I,2015.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709617,JANSSEN,,40.0,YR,A,F,Y,,,20150812.0,N,OT,US,US,2015,Q3,Adult
113700971,11370097,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,300.0,MG,TABLET,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,2015.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709617,JANSSEN,,40.0,YR,A,F,Y,,,20150812.0,N,OT,US,US,2015,Q3,Adult
113700971,11370097,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,300.0,MG,TABLET,QD,2015,Q3,Off label use,,2015,Q3,1,I,2015.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709617,JANSSEN,,40.0,YR,A,F,Y,,,20150812.0,N,OT,US,US,2015,Q3,Adult
113700971,11370097,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,300.0,MG,TABLET,QD,2015,Q3,Pneumonia,,2015,Q3,1,I,2015.0,20150713.0,20150812,20150812,PER,,US-JNJFOC-20150709617,JANSSEN,,40.0,YR,A,F,Y,,,20150812.0,N,OT,US,US,2015,Q3,Adult
113811971,11381197,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,CUMULATIVE DOSE: 1200 DOSES,,,,N,,,204042.0,100.0,DF,TABLET,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20150420.0,20150807.0,20150814,20150814,EXP,,GB-JNJFOC-20150804924,JANSSEN,,46.0,YR,A,M,Y,82.0,KG,20150814.0,N,MD,GB,GB,2015,Q3,Adult
114074951,11407495,2,SS,CANAGLIFLOZIN HEMIHYDRATE W/METFORMIN HYDROCH,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,D, UNKNOWN,,,,,,,2015,Q3,Decreased appetite,,2015,Q3,1,I,20141204.0,20141210.0,20150821,20150821,PER,,US-NOVOPROD-432321,NOVO NORDISK,,47.0,YR,A,F,Y,,,20150822.0,N,CN,US,US,2015,Q3,Adult
114074951,11407495,2,SS,CANAGLIFLOZIN HEMIHYDRATE W/METFORMIN HYDROCH,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,D, UNKNOWN,,,,,,,2015,Q3,Dizziness,,2015,Q3,1,I,20141204.0,20141210.0,20150821,20150821,PER,,US-NOVOPROD-432321,NOVO NORDISK,,47.0,YR,A,F,Y,,,20150822.0,N,CN,US,US,2015,Q3,Adult
114074951,11407495,2,SS,CANAGLIFLOZIN HEMIHYDRATE W/METFORMIN HYDROCH,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,D, UNKNOWN,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,20141204.0,20141210.0,20150821,20150821,PER,,US-NOVOPROD-432321,NOVO NORDISK,,47.0,YR,A,F,Y,,,20150822.0,N,CN,US,US,2015,Q3,Adult
114074951,11407495,2,SS,CANAGLIFLOZIN HEMIHYDRATE W/METFORMIN HYDROCH,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,D, UNKNOWN,,,,,,,2015,Q3,Vision blurred,,2015,Q3,1,I,20141204.0,20141210.0,20150821,20150821,PER,,US-NOVOPROD-432321,NOVO NORDISK,,47.0,YR,A,F,Y,,,20150822.0,N,CN,US,US,2015,Q3,Adult
114074951,11407495,2,SS,CANAGLIFLOZIN HEMIHYDRATE W/METFORMIN HYDROCH,CANAGLIFLOZIN\METFORMIN HYDROCHLORIDE,1,Oral,UNK,,,,D, UNKNOWN,,,,,,,2015,Q3,Vomiting,,2015,Q3,1,I,20141204.0,20141210.0,20150821,20150821,PER,,US-NOVOPROD-432321,NOVO NORDISK,,47.0,YR,A,F,Y,,,20150822.0,N,CN,US,US,2015,Q3,Adult
114115593,11411559,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 TABLET BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Rectal cancer,,2015,Q3,3,F,20150623.0,20150901.0,20150824,20150910,PER,,JP-JNJFOC-20150814297,JANSSEN,,55.0,YR,A,M,Y,50.0,KG,20150910.0,N,MD,JP,JP,2015,Q3,Adult
114158611,11415861,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,,,,QD,2015,Q3,Diabetic ketoacidosis,,2015,Q3,1,I,20150821.0,,20150824,20150824,DIR,,,,,56.0,YR,,M,N,118.0,KG,20150823.0,N,MD,US,,2015,Q3,Adult
114235281,11423528,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 DOSE,,,,U,,,204042.0,,,CAPSULE,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,20150703.0,20150820.0,20150827,20150827,EXP,,GB-JNJFOC-20150814327,JANSSEN,,53.0,YR,A,M,Y,142.0,KG,20150827.0,N,OT,GB,GB,2015,Q3,Adult
114235281,11423528,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 DOSE,,,,U,,,204042.0,,,CAPSULE,,2015,Q3,Blood ketone body,,2015,Q3,1,I,20150703.0,20150820.0,20150827,20150827,EXP,,GB-JNJFOC-20150814327,JANSSEN,,53.0,YR,A,M,Y,142.0,KG,20150827.0,N,OT,GB,GB,2015,Q3,Adult
114235281,11423528,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 DOSE,,,,U,,,204042.0,,,CAPSULE,,2015,Q3,Glomerular filtration rate decreased,,2015,Q3,1,I,20150703.0,20150820.0,20150827,20150827,EXP,,GB-JNJFOC-20150814327,JANSSEN,,53.0,YR,A,M,Y,142.0,KG,20150827.0,N,OT,GB,GB,2015,Q3,Adult
114235281,11423528,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,100 DOSE,,,,U,,,204042.0,,,CAPSULE,,2015,Q3,Oropharyngeal pain,,2015,Q3,1,I,20150703.0,20150820.0,20150827,20150827,EXP,,GB-JNJFOC-20150814327,JANSSEN,,53.0,YR,A,M,Y,142.0,KG,20150827.0,N,OT,GB,GB,2015,Q3,Adult
114314531,11431453,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,DOSE: 100,,,,N,,,204042.0,,,TABLET,,2015,Q3,Blood ketone body increased,,2015,Q3,1,I,20150808.0,20150824.0,20150828,20150828,EXP,,GB-JNJFOC-20150817361,JANSSEN,,3.0,DEC,A,M,Y,70.0,KG,20150828.0,N,MD,GB,GB,2015,Q3,Child
114314531,11431453,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,DOSE: 100,,,,N,,,204042.0,,,TABLET,,2015,Q3,Ketosis,,2015,Q3,1,I,20150808.0,20150824.0,20150828,20150828,EXP,,GB-JNJFOC-20150817361,JANSSEN,,3.0,DEC,A,M,Y,70.0,KG,20150828.0,N,MD,GB,GB,2015,Q3,Child
114321971,11432197,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B186106,,204042.0,,,CAPSULE,,2015,Q3,Cachexia,,2015,Q3,1,I,20150805.0,20150806.0,20150828,20150828,EXP,,ES-JNJFOC-20150804226,JANSSEN,,61.0,YR,A,M,Y,65.0,KG,20150828.0,N,MD,ES,ES,2015,Q3,Adult
114321971,11432197,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B186106,,76479.0,100.0,MG,CAPSULE,,2015,Q3,Cachexia,,2015,Q3,1,I,20150805.0,20150806.0,20150828,20150828,EXP,,ES-JNJFOC-20150804226,JANSSEN,,61.0,YR,A,M,Y,65.0,KG,20150828.0,N,MD,ES,ES,2015,Q3,Adult
114489512,11448951,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Cataract,,2015,Q3,2,F,20150824.0,20150831.0,20150902,20150908,PER,,JP-JNJFOC-20150900204,JANSSEN,,55.0,YR,A,M,Y,78.0,KG,20150908.0,N,OT,JP,JP,2015,Q3,Adult
114958441,11495844,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,100.0,MG,TABLET,,2015,Q3,Urine ketone body present,,2015,Q3,1,I,201508.0,20150905.0,20150911,20150911,EXP,,IN-JNJFOC-20150904836,JANSSEN,,27.0,YR,A,M,Y,102.0,KG,20150911.0,N,MD,IN,SG,2015,Q3,Young Adult
115037641,11503764,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Drug ineffective,,2015,Q3,1,I,20150827.0,20150828.0,20150914,20150914,PER,,US-BAYER-2015-411293,BAYER,,66.0,YR,E,M,Y,77.98,KG,20150914.0,N,CN,US,US,2015,Q3,Elderly
115037641,11503764,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,D,,,,,,,,2015,Q3,Product use issue,,2015,Q3,1,I,20150827.0,20150828.0,20150914,20150914,PER,,US-BAYER-2015-411293,BAYER,,66.0,YR,E,M,Y,77.98,KG,20150914.0,N,CN,US,US,2015,Q3,Elderly
115118032,11511803,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D,,,,100.0,MG,,,2015,Q3,Amnesia,,2015,Q3,2,F,20150521.0,20150616.0,20150915,20150915,EXP,GB-MHRA-EYC 00124277,GB-WATSON-2015-12932,WATSON,,77.0,YR,,M,Y,80.0,KG,20150915.0,N,CN,GB,GB,2015,Q3,Elderly
115118032,11511803,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D,,,,100.0,MG,,,2015,Q3,Blood glucose increased,,2015,Q3,2,F,20150521.0,20150616.0,20150915,20150915,EXP,GB-MHRA-EYC 00124277,GB-WATSON-2015-12932,WATSON,,77.0,YR,,M,Y,80.0,KG,20150915.0,N,CN,GB,GB,2015,Q3,Elderly
115118032,11511803,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D,,,,100.0,MG,,,2015,Q3,Confusional state,,2015,Q3,2,F,20150521.0,20150616.0,20150915,20150915,EXP,GB-MHRA-EYC 00124277,GB-WATSON-2015-12932,WATSON,,77.0,YR,,M,Y,80.0,KG,20150915.0,N,CN,GB,GB,2015,Q3,Elderly
115118032,11511803,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D,,,,100.0,MG,,,2015,Q3,Diabetes mellitus inadequate control,,2015,Q3,2,F,20150521.0,20150616.0,20150915,20150915,EXP,GB-MHRA-EYC 00124277,GB-WATSON-2015-12932,WATSON,,77.0,YR,,M,Y,80.0,KG,20150915.0,N,CN,GB,GB,2015,Q3,Elderly
115118032,11511803,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D,,,,100.0,MG,,,2015,Q3,Drug interaction,,2015,Q3,2,F,20150521.0,20150616.0,20150915,20150915,EXP,GB-MHRA-EYC 00124277,GB-WATSON-2015-12932,WATSON,,77.0,YR,,M,Y,80.0,KG,20150915.0,N,CN,GB,GB,2015,Q3,Elderly
115118032,11511803,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D,,,,100.0,MG,,,2015,Q3,Fasciitis,,2015,Q3,2,F,20150521.0,20150616.0,20150915,20150915,EXP,GB-MHRA-EYC 00124277,GB-WATSON-2015-12932,WATSON,,77.0,YR,,M,Y,80.0,KG,20150915.0,N,CN,GB,GB,2015,Q3,Elderly
115118032,11511803,10,I,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,"100 MG, UNK",,,,D,,,,100.0,MG,,,2015,Q3,Muscle spasms,,2015,Q3,2,F,20150521.0,20150616.0,20150915,20150915,EXP,GB-MHRA-EYC 00124277,GB-WATSON-2015-12932,WATSON,,77.0,YR,,M,Y,80.0,KG,20150915.0,N,CN,GB,GB,2015,Q3,Elderly
115182401,11518240,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Memory impairment,,2015,Q3,1,I,,20150907.0,20150917,20150917,EXP,,JP-JNJFOC-20150912370,JANSSEN,,6.0,DEC,A,F,Y,,,20150917.0,N,OT,JP,JP,2015,Q3,Child
115182401,11518240,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,100.0,MG,TABLET,QD,2015,Q3,Muscle rigidity,,2015,Q3,1,I,,20150907.0,20150917,20150917,EXP,,JP-JNJFOC-20150912370,JANSSEN,,6.0,DEC,A,F,Y,,,20150917.0,N,OT,JP,JP,2015,Q3,Child
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Abdominal discomfort,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Bladder cancer recurrent,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Bladder catheterisation,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Bladder repair,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Chest discomfort,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Chest pain,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Cystitis,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Decreased appetite,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Dizziness,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Dysphonia,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Dyspnoea exertional,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Faeces discoloured,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Fatigue,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Haemorrhage,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Heart rate abnormal,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Nausea,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Palpitations,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Productive cough,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Pyrexia,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Rhinorrhoea,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
109750575,10975057,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Vomiting,,2015,Q4,5,F,,20150925.0,20150401,20151006,EXP,,US-ACTELION-A-NJ2015-115321,ACTELION,,70.0,YR,E,F,Y,56.24,KG,20151007.0,,OT,US,US,2015,Q4,Elderly
110678704,11067870,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,100.0,MG,CAPSULE,,2015,Q4,Diarrhoea,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
110678704,11067870,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,100.0,MG,CAPSULE,,2015,Q4,Fatigue,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
110678704,11067870,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,100.0,MG,CAPSULE,,2015,Q4,Hyperkalaemia,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
110678704,11067870,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,300.0,MG,CAPSULE,QD,2015,Q4,Diarrhoea,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
110678704,11067870,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,300.0,MG,CAPSULE,QD,2015,Q4,Fatigue,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
110678704,11067870,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N, 14KG437,,,300.0,MG,CAPSULE,QD,2015,Q4,Hyperkalaemia,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
110678704,11067870,3,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,DRUG START TIME: 07:13 HOURS??DRUG END TIME: 08:00 HOURS,,,,N, 14KG437,,204042.0,300.0,MG,CAPSULE,QD,2015,Q4,Diarrhoea,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
110678704,11067870,3,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,DRUG START TIME: 07:13 HOURS??DRUG END TIME: 08:00 HOURS,,,,N, 14KG437,,204042.0,300.0,MG,CAPSULE,QD,2015,Q4,Fatigue,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
110678704,11067870,3,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,DRUG START TIME: 07:13 HOURS??DRUG END TIME: 08:00 HOURS,,,,N, 14KG437,,204042.0,300.0,MG,CAPSULE,QD,2015,Q4,Hyperkalaemia,,2015,Q4,4,F,20150407.0,20151104.0,20150427,20151110,EXP,,US-JNJFOC-20150414775,JANSSEN,,52.0,YR,A,M,Y,88.0,KG,20151110.0,,MD,US,US,2015,Q4,Adult
112241052,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q4,Amnesia,,2015,Q4,2,F,20150521.0,20150616.0,20150629,20151022,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20151022.0,,CN,GB,GB,2015,Q4,Elderly
112241052,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q4,Blood glucose increased,,2015,Q4,2,F,20150521.0,20150616.0,20150629,20151022,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20151022.0,,CN,GB,GB,2015,Q4,Elderly
112241052,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q4,Confusional state,,2015,Q4,2,F,20150521.0,20150616.0,20150629,20151022,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20151022.0,,CN,GB,GB,2015,Q4,Elderly
112241052,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q4,Diabetes mellitus inadequate control,,2015,Q4,2,F,20150521.0,20150616.0,20150629,20151022,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20151022.0,,CN,GB,GB,2015,Q4,Elderly
112241052,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q4,Drug interaction,,2015,Q4,2,F,20150521.0,20150616.0,20150629,20151022,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20151022.0,,CN,GB,GB,2015,Q4,Elderly
112241052,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q4,Fasciitis,,2015,Q4,2,F,20150521.0,20150616.0,20150629,20151022,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20151022.0,,CN,GB,GB,2015,Q4,Elderly
112241052,11224105,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U, EHZS000 07-2015,,204042.0,,,TABLET,,2015,Q4,Muscle spasms,,2015,Q4,2,F,20150521.0,20150616.0,20150629,20151022,EXP,,GB-JNJFOC-20150612357,JANSSEN,,77.0,YR,E,M,Y,80.0,KG,20151022.0,,CN,GB,GB,2015,Q4,Elderly
112339652,11233965,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,CAPSULE,,2015,Q4,Angina unstable,,2015,Q4,2,F,20150619.0,20151029.0,20150702,20151112,EXP,,CA-JNJFOC-20150617843,JANSSEN,,56.0,YR,A,M,Y,82.4,KG,20151112.0,,MD,CA,CA,2015,Q4,Adult
112339652,11233965,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,76479.0,100.0,MG,CAPSULE,,2015,Q4,Angina unstable,,2015,Q4,2,F,20150619.0,20151029.0,20150702,20151112,EXP,,CA-JNJFOC-20150617843,JANSSEN,,56.0,YR,A,M,Y,82.4,KG,20151112.0,,MD,CA,CA,2015,Q4,Adult
113987475,11398747,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q4,Colon cancer,,2015,Q4,5,F,20150721.0,20151030.0,20150820,20151109,EXP,,JP-JNJFOC-20150812230,JANSSEN,,65.0,YR,A,M,Y,72.0,KG,20151109.0,,MD,JP,JP,2015,Q4,Elderly
114115594,11411559,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,1 TABLET BEFORE BREAKFAST WITH WATER,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q4,Rectal cancer,,2015,Q4,4,F,20150623.0,20150901.0,20150824,20151231,EXP,,JP-JNJFOC-20150814297,JANSSEN,,55.0,YR,A,M,Y,50.0,KG,20151231.0,,MD,JP,JP,2015,Q4,Adult
115292594,11529259,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,CAPSULE,,2015,Q4,Adenocarcinoma gastric,,2015,Q4,4,F,20150911.0,20151014.0,20150921,20151022,PER,,ES-JNJFOC-20150909868,JANSSEN,,80.0,YR,E,M,Y,,,20151022.0,,MD,ES,ES,2015,Q4,Elderly
115292594,11529259,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,76479.0,300.0,MG,CAPSULE,QD,2015,Q4,Adenocarcinoma gastric,,2015,Q4,4,F,20150911.0,20151014.0,20150921,20151022,PER,,ES-JNJFOC-20150909868,JANSSEN,,80.0,YR,E,M,Y,,,20151022.0,,MD,ES,ES,2015,Q4,Elderly
115501955,11550195,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Fluid overload,,2015,Q4,5,F,20150914.0,20151214.0,20150924,20151224,EXP,,US-ACTELION-A-US2015-124186,ACTELION,,59.0,YR,A,F,Y,,,20151224.0,,OT,US,US,2015,Q4,Adult
115501955,11550195,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Heart and lung transplant,,2015,Q4,5,F,20150914.0,20151214.0,20150924,20151224,EXP,,US-ACTELION-A-US2015-124186,ACTELION,,59.0,YR,A,F,Y,,,20151224.0,,OT,US,US,2015,Q4,Adult
115501955,11550195,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,U,,,,,,,,2015,Q4,Post procedural complication,,2015,Q4,5,F,20150914.0,20151214.0,20150924,20151224,EXP,,US-ACTELION-A-US2015-124186,ACTELION,,59.0,YR,A,F,Y,,,20151224.0,,OT,US,US,2015,Q4,Adult
116168833,11616883,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B186322,,204042.0,,,CAPSULE,,2015,Q4,Perinephric abscess,,2015,Q4,3,F,20150507.0,20151104.0,20151009,20151110,EXP,,ES-JNJFOC-20150506677,JANSSEN,,72.0,YR,E,M,Y,82.5,KG,20151110.0,,MD,ES,ES,2015,Q4,Elderly
116168833,11616883,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B186322,,204042.0,,,CAPSULE,,2015,Q4,Septic shock,,2015,Q4,3,F,20150507.0,20151104.0,20151009,20151110,EXP,,ES-JNJFOC-20150506677,JANSSEN,,72.0,YR,E,M,Y,82.5,KG,20151110.0,,MD,ES,ES,2015,Q4,Elderly
116168833,11616883,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B186322,,76479.0,300.0,MG,CAPSULE,,2015,Q4,Perinephric abscess,,2015,Q4,3,F,20150507.0,20151104.0,20151009,20151110,EXP,,ES-JNJFOC-20150506677,JANSSEN,,72.0,YR,E,M,Y,82.5,KG,20151110.0,,MD,ES,ES,2015,Q4,Elderly
116168833,11616883,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B186322,,76479.0,300.0,MG,CAPSULE,,2015,Q4,Septic shock,,2015,Q4,3,F,20150507.0,20151104.0,20151009,20151110,EXP,,ES-JNJFOC-20150506677,JANSSEN,,72.0,YR,E,M,Y,82.5,KG,20151110.0,,MD,ES,ES,2015,Q4,Elderly
116173111,11617311,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,100.0,MG,TABLET,QD,2015,Q4,Abnormal behaviour,,2015,Q4,1,I,20150826.0,20151002.0,20151009,20151009,EXP,,GB-JNJFOC-20151004121,JANSSEN,,56.0,YR,A,F,Y,94.0,KG,20151009.0,,MD,GB,GB,2015,Q4,Adult
116173111,11617311,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,100.0,MG,TABLET,QD,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20150826.0,20151002.0,20151009,20151009,EXP,,GB-JNJFOC-20151004121,JANSSEN,,56.0,YR,A,F,Y,94.0,KG,20151009.0,,MD,GB,GB,2015,Q4,Adult
116173111,11617311,1,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,,100.0,MG,TABLET,QD,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20150826.0,20151002.0,20151009,20151009,EXP,,GB-JNJFOC-20151004121,JANSSEN,,56.0,YR,A,F,Y,94.0,KG,20151009.0,,MD,GB,GB,2015,Q4,Adult
116173111,11617311,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300.0,MG,TABLET,QD,2015,Q4,Abnormal behaviour,,2015,Q4,1,I,20150826.0,20151002.0,20151009,20151009,EXP,,GB-JNJFOC-20151004121,JANSSEN,,56.0,YR,A,F,Y,94.0,KG,20151009.0,,MD,GB,GB,2015,Q4,Adult
116173111,11617311,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300.0,MG,TABLET,QD,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20150826.0,20151002.0,20151009,20151009,EXP,,GB-JNJFOC-20151004121,JANSSEN,,56.0,YR,A,F,Y,94.0,KG,20151009.0,,MD,GB,GB,2015,Q4,Adult
116173111,11617311,2,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300.0,MG,TABLET,QD,2015,Q4,Hyponatraemia,,2015,Q4,1,I,20150826.0,20151002.0,20151009,20151009,EXP,,GB-JNJFOC-20151004121,JANSSEN,,56.0,YR,A,F,Y,94.0,KG,20151009.0,,MD,GB,GB,2015,Q4,Adult
116196773,11619677,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4369483,,204042.0,,,CAPSULE,,2015,Q4,Hyponatraemia,,2015,Q4,3,F,20150922.0,20151022.0,20151012,20151030,EXP,,HU-JNJFOC-20151001550,JANSSEN,,73.0,YR,E,M,Y,78.0,KG,20151030.0,,MD,HU,HU,2015,Q4,Elderly
116196773,11619677,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 4369483,,76479.0,100.0,MG,CAPSULE,QD,2015,Q4,Hyponatraemia,,2015,Q4,3,F,20150922.0,20151022.0,20151012,20151030,EXP,,HU-JNJFOC-20151001550,JANSSEN,,73.0,YR,E,M,Y,78.0,KG,20151030.0,,MD,HU,HU,2015,Q4,Elderly
116235231,11623523,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Drug ineffective for unapproved indication,,2015,Q4,1,I,,20150324.0,20151013,20151013,PER,,US-JNJFOC-20150322759,JANSSEN,,74.0,YR,E,F,Y,97.52,KG,20151013.0,,CN,US,US,2015,Q4,Elderly
116235231,11623523,4,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Product use issue,,2015,Q4,1,I,,20150324.0,20151013,20151013,PER,,US-JNJFOC-20150322759,JANSSEN,,74.0,YR,E,F,Y,97.52,KG,20151013.0,,CN,US,US,2015,Q4,Elderly
116294995,11629499,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,CAPSULE,,2015,Q4,Basilar artery occlusion,,2015,Q4,5,F,20151005.0,20151224.0,20151014,20151228,EXP,,KR-JNJFOC-20151005607,JANSSEN,,77.0,YR,E,M,Y,70.0,KG,20151228.0,,MD,KR,KR,2015,Q4,Elderly
116294995,11629499,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,76479.0,300.0,MG,CAPSULE,QD,2015,Q4,Basilar artery occlusion,,2015,Q4,5,F,20151005.0,20151224.0,20151014,20151228,EXP,,KR-JNJFOC-20151005607,JANSSEN,,77.0,YR,E,M,Y,70.0,KG,20151228.0,,MD,KR,KR,2015,Q4,Elderly
116295251,11629525,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,,,,,300.0,MG,,QD,2015,Q4,Ketoacidosis,,2015,Q4,1,I,20151010.0,,20151013,20151013,DIR,,,,,59.0,YR,,F,N,,,20151010.0,N,OT,US,,2015,Q4,Adult
116384131,11638413,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,N,,,204042.0,300.0,MG,TABLET,QD,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,,20151007.0,20151016,20151016,EXP,,US-JNJFOC-20151005662,JANSSEN,"GHOFRANI H,  WONG C,  SMOGORZEWSKI M. SEVERE KETOACIDOSIS AFTER BARIATRIC SURGERY IN A PATIENT TREATED WITH CANAGLIFLOZIN.",38.0,YR,A,M,Y,,,20151016.0,,MD,US,US,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Blood bicarbonate decreased,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Blood creatinine increased,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Blood ketone body increased,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Blood phosphorus decreased,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Blood urea increased,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Glucose urine present,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Hypercalcaemia,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Hypernatraemia,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Mental status changes,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Polyuria,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116430711,11643071,2,SS,"CANAGLIFLOZIN (CANAGLIFLOZIN), EHZS000 07-2015",CANAGLIFLOZIN,1,,,,,Y,D,,,,,,,,2015,Q4,Syncope,,2015,Q4,1,I,,20150907.0,20151016,20151016,EXP,,US2015GSK127948,GLAXOSMITHKLINE,,60.0,YR,,M,N,,,20151015.0,N,,US,,2015,Q4,Adult
116550781,11655078,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,100.0,MG,TABLET,QD,2015,Q4,Blood ketone body increased,,2015,Q4,1,I,20150917.0,20151005.0,20151023,20151023,EXP,,JP-JNJFOC-20151012617,JANSSEN,,64.0,YR,A,M,Y,70.0,KG,20151023.0,,OT,JP,JP,2015,Q4,Adult
116550781,11655078,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,U,,,204042.0,100.0,MG,TABLET,QD,2015,Q4,Urine ketone body present,,2015,Q4,1,I,20150917.0,20151005.0,20151023,20151023,EXP,,JP-JNJFOC-20151012617,JANSSEN,,64.0,YR,A,M,Y,70.0,KG,20151023.0,,OT,JP,JP,2015,Q4,Adult
117003267,11700326,1,PS,CANAGLIFLOZIN 10% MONOHYDRATE/90% HEMIHYDRATE,CANAGLIFLOZIN,1,Oral,,,,,N, FGTK000,,204042.0,300.0,MG,TABLET,,2015,Q4,Ischaemic cerebral infarction,,2015,Q4,7,F,20151027.0,20151209.0,20151105,20151210,EXP,,NL-JNJFOC-20151021608,JANSSEN,,46.0,YR,A,F,Y,65.0,KG,20151210.0,,MD,NL,BE,2015,Q4,Adult
117039631,11703963,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL,,,D,D,,,,,,,QD,2015,Q4,Dehydration,,2015,Q4,1,I,20151102.0,,20151105,20151105,DIR,,,,,44.0,YR,,M,N,86.8,KG,20151104.0,N,PH,US,,2015,Q4,Adult
117039631,11703963,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL,,,D,D,,,,,,,QD,2015,Q4,Ketoacidosis,,2015,Q4,1,I,20151102.0,,20151105,20151105,DIR,,,,,44.0,YR,,M,N,86.8,KG,20151104.0,N,PH,US,,2015,Q4,Adult
117039631,11703963,1,PS,CANAGLIFLOZIN 300 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL,,,D,D,,,,,,,QD,2015,Q4,Metabolic acidosis,,2015,Q4,1,I,20151102.0,,20151105,20151105,DIR,,,,,44.0,YR,,M,N,86.8,KG,20151104.0,N,PH,US,,2015,Q4,Adult
117136621,11713662,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300.0,MG,TABLET,,2015,Q4,Base excess negative,,2015,Q4,1,I,20151016.0,20151106.0,20151109,20151109,EXP,,GB-JNJFOC-20151107062,JANSSEN,,70.0,YR,E,F,Y,70.0,KG,20151109.0,,MD,GB,GB,2015,Q4,Elderly
117136621,11713662,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300.0,MG,TABLET,,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151016.0,20151106.0,20151109,20151109,EXP,,GB-JNJFOC-20151107062,JANSSEN,,70.0,YR,E,F,Y,70.0,KG,20151109.0,,MD,GB,GB,2015,Q4,Elderly
117136621,11713662,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300.0,MG,TABLET,,2015,Q4,Polyuria,,2015,Q4,1,I,20151016.0,20151106.0,20151109,20151109,EXP,,GB-JNJFOC-20151107062,JANSSEN,,70.0,YR,E,F,Y,70.0,KG,20151109.0,,MD,GB,GB,2015,Q4,Elderly
117136621,11713662,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300.0,MG,TABLET,,2015,Q4,Thirst,,2015,Q4,1,I,20151016.0,20151106.0,20151109,20151109,EXP,,GB-JNJFOC-20151107062,JANSSEN,,70.0,YR,E,F,Y,70.0,KG,20151109.0,,MD,GB,GB,2015,Q4,Elderly
117136621,11713662,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,300.0,MG,TABLET,,2015,Q4,Vomiting,,2015,Q4,1,I,20151016.0,20151106.0,20151109,20151109,EXP,,GB-JNJFOC-20151107062,JANSSEN,,70.0,YR,E,F,Y,70.0,KG,20151109.0,,MD,GB,GB,2015,Q4,Elderly
117181271,11718127,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,100.0 UNITS NOT PROVIDED,,,,U,,,204042.0,,,TABLET,,2015,Q4,Mobility decreased,,2015,Q4,1,I,20150826.0,20151103.0,20151110,20151110,EXP,,GB-JNJFOC-20151102021,JANSSEN,,67.0,YR,E,M,Y,97.0,KG,20151110.0,,MD,GB,GB,2015,Q4,Elderly
117182561,11718256,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Acute kidney injury,,2015,Q4,1,I,20151107.0,,20151109,20151109,DIR,,,,,77.0,YR,,M,N,114.0,KG,20151107.0,N,PH,US,,2015,Q4,Elderly
117182561,11718256,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Blood glucose increased,,2015,Q4,1,I,20151107.0,,20151109,20151109,DIR,,,,,77.0,YR,,M,N,114.0,KG,20151107.0,N,PH,US,,2015,Q4,Elderly
117182561,11718256,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,D,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Metabolic acidosis,,2015,Q4,1,I,20151107.0,,20151109,20151109,DIR,,,,,77.0,YR,,M,N,114.0,KG,20151107.0,N,PH,US,,2015,Q4,Elderly
117459301,11745930,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,TABLET,,2015,Q4,Angioedema,,2015,Q4,1,I,20151022.0,20151110.0,20151117,20151117,EXP,,GB-JNJFOC-20151111119,JANSSEN,,56.0,YR,A,M,Y,86.0,KG,20151117.0,,MD,GB,GB,2015,Q4,Adult
117540452,11754045,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,MG,TABLET,QD,2015,Q4,Prostate cancer,,2015,Q4,2,F,20151109.0,20151212.0,20151119,20151218,EXP,,JP-JNJFOC-20151118609,JANSSEN,,62.0,YR,A,M,Y,78.0,KG,20151218.0,,OT,JP,JP,2015,Q4,Adult
117582421,11758242,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B186322,,204042.0,,,CAPSULE,,2015,Q4,Prostatitis,,2015,Q4,1,I,20151031.0,20151103.0,20151120,20151120,PER,,TW-JNJFOC-20151103161,JANSSEN,,60.0,YR,A,M,Y,65.0,KG,20151120.0,,MD,TW,TW,2015,Q4,Adult
117582421,11758242,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, B186322,,76479.0,300.0,MG,CAPSULE,QD,2015,Q4,Prostatitis,,2015,Q4,1,I,20151031.0,20151103.0,20151120,20151120,PER,,TW-JNJFOC-20151103161,JANSSEN,,60.0,YR,A,M,Y,65.0,KG,20151120.0,,MD,TW,TW,2015,Q4,Adult
117720531,11772053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,,,TABLET,,2015,Q4,Abnormal behaviour,,2015,Q4,1,I,20151009.0,20151116.0,20151124,20151124,EXP,,GB-JNJFOC-20151116319,JANSSEN,,82.0,YR,E,M,Y,63.0,KG,20151124.0,,MD,GB,GB,2015,Q4,Elderly
117720531,11772053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,,,TABLET,,2015,Q4,Decreased appetite,,2015,Q4,1,I,20151009.0,20151116.0,20151124,20151124,EXP,,GB-JNJFOC-20151116319,JANSSEN,,82.0,YR,E,M,Y,63.0,KG,20151124.0,,MD,GB,GB,2015,Q4,Elderly
117720531,11772053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,,,TABLET,,2015,Q4,Fear,,2015,Q4,1,I,20151009.0,20151116.0,20151124,20151124,EXP,,GB-JNJFOC-20151116319,JANSSEN,,82.0,YR,E,M,Y,63.0,KG,20151124.0,,MD,GB,GB,2015,Q4,Elderly
117720531,11772053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,,,TABLET,,2015,Q4,Musculoskeletal stiffness,,2015,Q4,1,I,20151009.0,20151116.0,20151124,20151124,EXP,,GB-JNJFOC-20151116319,JANSSEN,,82.0,YR,E,M,Y,63.0,KG,20151124.0,,MD,GB,GB,2015,Q4,Elderly
117720531,11772053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,,,TABLET,,2015,Q4,Parkinson's disease,,2015,Q4,1,I,20151009.0,20151116.0,20151124,20151124,EXP,,GB-JNJFOC-20151116319,JANSSEN,,82.0,YR,E,M,Y,63.0,KG,20151124.0,,MD,GB,GB,2015,Q4,Elderly
117720531,11772053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,,,TABLET,,2015,Q4,Polydipsia,,2015,Q4,1,I,20151009.0,20151116.0,20151124,20151124,EXP,,GB-JNJFOC-20151116319,JANSSEN,,82.0,YR,E,M,Y,63.0,KG,20151124.0,,MD,GB,GB,2015,Q4,Elderly
117720531,11772053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,,,TABLET,,2015,Q4,Tension,,2015,Q4,1,I,20151009.0,20151116.0,20151124,20151124,EXP,,GB-JNJFOC-20151116319,JANSSEN,,82.0,YR,E,M,Y,63.0,KG,20151124.0,,MD,GB,GB,2015,Q4,Elderly
117720531,11772053,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,U,,,204042.0,,,TABLET,,2015,Q4,Thirst,,2015,Q4,1,I,20151009.0,20151116.0,20151124,20151124,EXP,,GB-JNJFOC-20151116319,JANSSEN,,82.0,YR,E,M,Y,63.0,KG,20151124.0,,MD,GB,GB,2015,Q4,Elderly
117720611,11772061,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,DOSE:100,,,,N,,,204042.0,,,TABLET,,2015,Q4,Oral mucosal blistering,,2015,Q4,1,I,20151103.0,20151117.0,20151124,20151124,EXP,,GB-JNJFOC-20151117912,JANSSEN,,68.0,YR,E,M,Y,112.0,KG,20151124.0,,OT,GB,GB,2015,Q4,Elderly
117720611,11772061,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,DOSE:100,,,,N,,,204042.0,,,TABLET,,2015,Q4,Tongue blistering,,2015,Q4,1,I,20151103.0,20151117.0,20151124,20151124,EXP,,GB-JNJFOC-20151117912,JANSSEN,,68.0,YR,E,M,Y,112.0,KG,20151124.0,,OT,GB,GB,2015,Q4,Elderly
117781401,11778140,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Pancreatitis acute,,2015,Q4,1,I,20150929.0,20151110.0,20151125,20151125,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-080590,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,110.0,KG,20151125.0,,MD,US,US,2015,Q4,Elderly
117829081,11782908,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,DOSE WAS 100 (UNITS UNSPECIFIED),,,,N,,,204042.0,,,TABLET,,2015,Q4,Anaemia,,2015,Q4,1,I,201508.0,20151124.0,20151127,20151127,EXP,,GB-JNJFOC-20151123164,JANSSEN,,61.0,YR,A,F,Y,66.8,KG,20151127.0,,PH,GB,GB,2015,Q4,Adult
117829081,11782908,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,DOSE WAS 100 (UNITS UNSPECIFIED),,,,N,,,204042.0,,,TABLET,,2015,Q4,Colon cancer,,2015,Q4,1,I,201508.0,20151124.0,20151127,20151127,EXP,,GB-JNJFOC-20151123164,JANSSEN,,61.0,YR,A,F,Y,66.8,KG,20151127.0,,PH,GB,GB,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Cardiac arrest,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Cardiomegaly,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Chest pain,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Circulatory collapse,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Diarrhoea,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Fatigue,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Hepatic fibrosis,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Hepatic steatosis,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Hyperhidrosis,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Movement disorder,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Nausea,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Pulmonary oedema,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Sudden death,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Thirst,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Ventricular hypertrophy,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117850991,11785099,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Vomiting,,2015,Q4,1,I,20150920.0,,20151125,20151125,DIR,,,,,64.0,YR,,M,N,257.0,LBS,20151124.0,N,,US,,2015,Q4,Adult
117934751,11793475,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Abdominal pain,,2015,Q4,1,I,20151127.0,,20151201,20151201,DIR,,,,,54.0,YR,,M,N,,,20151130.0,N,MD,US,,2015,Q4,Adult
117934751,11793475,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Blood glucose increased,,2015,Q4,1,I,20151127.0,,20151201,20151201,DIR,,,,,54.0,YR,,M,N,,,20151130.0,N,MD,US,,2015,Q4,Adult
117934751,11793475,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151127.0,,20151201,20151201,DIR,,,,,54.0,YR,,M,N,,,20151130.0,N,MD,US,,2015,Q4,Adult
117934751,11793475,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Nausea,,2015,Q4,1,I,20151127.0,,20151201,20151201,DIR,,,,,54.0,YR,,M,N,,,20151130.0,N,MD,US,,2015,Q4,Adult
117934751,11793475,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Vomiting,,2015,Q4,1,I,20151127.0,,20151201,20151201,DIR,,,,,54.0,YR,,M,N,,,20151130.0,N,MD,US,,2015,Q4,Adult
117969561,11796956,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL  QD  ORAL,,,Y,D,,,,1.0,DF,,QD,2015,Q4,Abdominal pain,,2015,Q4,1,I,20151127.0,,20151202,20151202,DIR,,,,,47.0,YR,,M,N,78.0,KG,20151201.0,N,PH,US,,2015,Q4,Adult
117969561,11796956,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL  QD  ORAL,,,Y,D,,,,1.0,DF,,QD,2015,Q4,Acute coronary syndrome,,2015,Q4,1,I,20151127.0,,20151202,20151202,DIR,,,,,47.0,YR,,M,N,78.0,KG,20151201.0,N,PH,US,,2015,Q4,Adult
117969561,11796956,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL  QD  ORAL,,,Y,D,,,,1.0,DF,,QD,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151127.0,,20151202,20151202,DIR,,,,,47.0,YR,,M,N,78.0,KG,20151201.0,N,PH,US,,2015,Q4,Adult
117969561,11796956,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL  QD  ORAL,,,Y,D,,,,1.0,DF,,QD,2015,Q4,Metabolic acidosis,,2015,Q4,1,I,20151127.0,,20151202,20151202,DIR,,,,,47.0,YR,,M,N,78.0,KG,20151201.0,N,PH,US,,2015,Q4,Adult
117969561,11796956,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,1 PILL  QD  ORAL,,,Y,D,,,,1.0,DF,,QD,2015,Q4,Nausea,,2015,Q4,1,I,20151127.0,,20151202,20151202,DIR,,,,,47.0,YR,,M,N,78.0,KG,20151201.0,N,PH,US,,2015,Q4,Adult
118017501,11801750,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2015,Q4,Blood glucose increased,,2015,Q4,1,I,20151027.0,,20151203,20151203,DIR,,,,,36.0,YR,,F,N,46.0,KG,20151202.0,N,PH,US,,2015,Q4,Adult
118017501,11801750,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151027.0,,20151203,20151203,DIR,,,,,36.0,YR,,F,N,46.0,KG,20151202.0,N,PH,US,,2015,Q4,Adult
118017501,11801750,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2015,Q4,Drug dose omission,,2015,Q4,1,I,20151027.0,,20151203,20151203,DIR,,,,,36.0,YR,,F,N,46.0,KG,20151202.0,N,PH,US,,2015,Q4,Adult
118017501,11801750,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2015,Q4,Loss of consciousness,,2015,Q4,1,I,20151027.0,,20151203,20151203,DIR,,,,,36.0,YR,,F,N,46.0,KG,20151202.0,N,PH,US,,2015,Q4,Adult
118017501,11801750,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2015,Q4,Nausea,,2015,Q4,1,I,20151027.0,,20151203,20151203,DIR,,,,,36.0,YR,,F,N,46.0,KG,20151202.0,N,PH,US,,2015,Q4,Adult
118017501,11801750,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,,,,QD,2015,Q4,Vomiting,,2015,Q4,1,I,20151027.0,,20151203,20151203,DIR,,,,,36.0,YR,,F,N,46.0,KG,20151202.0,N,PH,US,,2015,Q4,Adult
118233141,11823314,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,26395.833,MG,,,,,,100.0,MG,,QD,2015,Q4,Anaemia,,2015,Q4,1,I,201508.0,20151124.0,20151210,20151210,EXP,,GB-ASTRAZENECA-2015SF19269,ASTRAZENECA,,61.0,YR,,F,Y,66.8,KG,20151210.0,,PH,GB,GB,2015,Q4,Adult
118233141,11823314,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,26395.833,MG,,,,,,100.0,MG,,QD,2015,Q4,Colon cancer,,2015,Q4,1,I,201508.0,20151124.0,20151210,20151210,EXP,,GB-ASTRAZENECA-2015SF19269,ASTRAZENECA,,61.0,YR,,F,Y,66.8,KG,20151210.0,,PH,GB,GB,2015,Q4,Adult
118450841,11845084,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151212.0,,20151216,20151216,DIR,,,,,62.0,YR,,F,N,97.0,KG,20151215.0,N,PH,US,,2015,Q4,Adult
118492621,11849262,1,PS,CANAGLIFLOZIN 300MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Creatinine renal clearance decreased,,2015,Q4,1,I,20151205.0,,20151217,20151217,DIR,,,,,54.0,YR,,F,N,338.0,LBS,20151216.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118492621,11849262,1,PS,CANAGLIFLOZIN 300MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Dehydration,,2015,Q4,1,I,20151205.0,,20151217,20151217,DIR,,,,,54.0,YR,,F,N,338.0,LBS,20151216.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118492621,11849262,1,PS,CANAGLIFLOZIN 300MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Diarrhoea,,2015,Q4,1,I,20151205.0,,20151217,20151217,DIR,,,,,54.0,YR,,F,N,338.0,LBS,20151216.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118492621,11849262,1,PS,CANAGLIFLOZIN 300MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Hypophagia,,2015,Q4,1,I,20151205.0,,20151217,20151217,DIR,,,,,54.0,YR,,F,N,338.0,LBS,20151216.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118492621,11849262,1,PS,CANAGLIFLOZIN 300MG,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Nausea,,2015,Q4,1,I,20151205.0,,20151217,20151217,DIR,,,,,54.0,YR,,F,N,338.0,LBS,20151216.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118601491,11860149,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,100.0,DF,TABLET,,2015,Q4,Atrioventricular block complete,,2015,Q4,1,I,20151125.0,20151218.0,20151222,20151222,EXP,,GB-JNJFOC-20151216204,JANSSEN,,74.0,YR,E,M,Y,,,20151222.0,,MD,GB,GB,2015,Q4,Elderly
118601521,11860152,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,204042.0,,,CAPSULE,,2015,Q4,Cardiac failure,,2015,Q4,1,I,20150926.0,20151215.0,20151222,20151222,EXP,,HU-JNJFOC-20151216036,JANSSEN,,73.0,YR,E,M,Y,113.2,KG,20151222.0,,MD,HU,HU,2015,Q4,Elderly
118601521,11860152,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N,,,76479.0,300.0,MG,CAPSULE,QD,2015,Q4,Cardiac failure,,2015,Q4,1,I,20150926.0,20151215.0,20151222,20151222,EXP,,HU-JNJFOC-20151216036,JANSSEN,,73.0,YR,E,M,Y,113.2,KG,20151222.0,,MD,HU,HU,2015,Q4,Elderly
118665501,11866550,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,21.0,DF,,,,,,1.0,DF,,QD,2015,Q4,Suicidal ideation,,2015,Q4,1,I,20151207.0,20151216.0,20151224,20151224,EXP,GB-MHRA-ADR 23266444,GB-ACCORD-036509,ACCORD,,69.0,YR,,F,Y,99.0,KG,20151224.0,,MD,GB,GB,2015,Q4,Elderly
118704031,11870403,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,1.0,DF,,QD,2015,Q4,Suicidal ideation,,2015,Q4,1,I,20150727.0,20151216.0,20151228,20151228,EXP,,GB-HOSPIRA-3118941,HOSPIRA,,69.0,YR,E,F,Y,99.0,KG,20151228.0,,MD,GB,GB,2015,Q4,Elderly
118706701,11870670,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Metabolic acidosis,,2015,Q4,1,I,20150917.0,,20151223,20151223,DIR,,,,,51.0,YR,,F,N,88.9,KG,20151222.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118706701,11870670,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,No therapeutic response,,2015,Q4,1,I,20150917.0,,20151223,20151223,DIR,,,,,51.0,YR,,F,N,88.9,KG,20151222.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118706701,11870670,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Urinary tract infection,,2015,Q4,1,I,20150917.0,,20151223,20151223,DIR,,,,,51.0,YR,,F,N,88.9,KG,20151222.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118706701,11870670,1,PS,CANAGLIFLOZIN 100 MG JANSSEN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,1.0,DF,COATED TABLET,QD,2015,Q4,Urine ketone body present,,2015,Q4,1,I,20150917.0,,20151223,20151223,DIR,,,,,51.0,YR,,F,N,88.9,KG,20151222.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118706701,11870670,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Metabolic acidosis,,2015,Q4,1,I,20150917.0,,20151223,20151223,DIR,,,,,51.0,YR,,F,N,88.9,KG,20151222.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118706701,11870670,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,No therapeutic response,,2015,Q4,1,I,20150917.0,,20151223,20151223,DIR,,,,,51.0,YR,,F,N,88.9,KG,20151222.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118706701,11870670,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Urinary tract infection,,2015,Q4,1,I,20150917.0,,20151223,20151223,DIR,,,,,51.0,YR,,F,N,88.9,KG,20151222.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118706701,11870670,21,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,,,,,,,,,,,,,2015,Q4,Urine ketone body present,,2015,Q4,1,I,20150917.0,,20151223,20151223,DIR,,,,,51.0,YR,,F,N,88.9,KG,20151222.0,N,PH,COUNTRY NOT SPECIFIED,,2015,Q4,Adult
118711791,11871179,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300.0,MG,,QD,2015,Q4,Ketoacidosis,,2015,Q4,1,I,20151119.0,,20151224,20151224,DIR,,,,,63.0,YR,,M,N,,,20151223.0,N,PH,US,,2015,Q4,Adult
118711791,11871179,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300.0,MG,,QD,2015,Q4,Metabolic acidosis,,2015,Q4,1,I,20151119.0,,20151224,20151224,DIR,,,,,63.0,YR,,M,N,,,20151223.0,N,PH,US,,2015,Q4,Adult
118711791,11871179,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,D,,,,300.0,MG,,QD,2015,Q4,Post procedural complication,,2015,Q4,1,I,20151119.0,,20151224,20151224,DIR,,,,,63.0,YR,,M,N,,,20151223.0,N,PH,US,,2015,Q4,Adult
118713061,11871306,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,N,,,,100.0,MG,,QD,2015,Q4,Decreased appetite,,2015,Q4,1,I,20151110.0,,20151224,20151224,DIR,,,,,66.0,YR,,M,N,,,20151111.0,N,PH,US,,2015,Q4,Elderly
118713061,11871306,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,N,,,,100.0,MG,,QD,2015,Q4,Dizziness,,2015,Q4,1,I,20151110.0,,20151224,20151224,DIR,,,,,66.0,YR,,M,N,,,20151111.0,N,PH,US,,2015,Q4,Elderly
118713061,11871306,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,N,,,,100.0,MG,,QD,2015,Q4,Fatigue,,2015,Q4,1,I,20151110.0,,20151224,20151224,DIR,,,,,66.0,YR,,M,N,,,20151111.0,N,PH,US,,2015,Q4,Elderly
118713061,11871306,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,N,,,,100.0,MG,,QD,2015,Q4,Ketoacidosis,,2015,Q4,1,I,20151110.0,,20151224,20151224,DIR,,,,,66.0,YR,,M,N,,,20151111.0,N,PH,US,,2015,Q4,Elderly
118713061,11871306,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,Y,N,,,,100.0,MG,,QD,2015,Q4,Laboratory test abnormal,,2015,Q4,1,I,20151110.0,,20151224,20151224,DIR,,,,,66.0,YR,,M,N,,,20151111.0,N,PH,US,,2015,Q4,Elderly
118733761,11873376,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,,1 DOSAGE FORMS DAILY;,21.0,DF,,,,,,1.0,DF,,QD,2015,Q4,Suicidal ideation,,2015,Q4,1,I,20151207.0,20151216.0,20151228,20151228,EXP,GB-MHRA-TPP10319849C956668YC1449516556702,GB-TEVA-619668ACC,TEVA,,69.0,YR,,F,Y,99.0,KG,20151229.0,,MD,GB,GB,2015,Q4,Elderly
118737361,11873736,5,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,21.0,DF,,,,,,1.0,DF,,QD,2015,Q4,Suicidal ideation,,2015,Q4,1,I,20151207.0,20151216.0,20151229,20151229,EXP,GB-MHRA-TPP10319849C956668YC1449516556702,PHHY2015GB165132,SANDOZ,,69.0,YR,,F,Y,99.0,KG,20151229.0,,OT,GB,GB,2015,Q4,Elderly
118746711,11874671,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,D,,,,,,,QD,2015,Q4,Acute respiratory failure,,2015,Q4,1,I,20151220.0,,20151228,20151228,DIR,,,,,29.0,YR,,F,N,67.1,KG,20151226.0,N,MD,US,,2015,Q4,Young Adult
118746711,11874671,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,D,,,,,,,QD,2015,Q4,Brain death,,2015,Q4,1,I,20151220.0,,20151228,20151228,DIR,,,,,29.0,YR,,F,N,67.1,KG,20151226.0,N,MD,US,,2015,Q4,Young Adult
118746711,11874671,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,D,,,,,,,QD,2015,Q4,Cardiac arrest,,2015,Q4,1,I,20151220.0,,20151228,20151228,DIR,,,,,29.0,YR,,F,N,67.1,KG,20151226.0,N,MD,US,,2015,Q4,Young Adult
118746711,11874671,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,D,,,,,,,QD,2015,Q4,Diabetic ketoacidosis,,2015,Q4,1,I,20151220.0,,20151228,20151228,DIR,,,,,29.0,YR,,F,N,67.1,KG,20151226.0,N,MD,US,,2015,Q4,Young Adult
118746711,11874671,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,D,,,,,,,QD,2015,Q4,Hypothermia,,2015,Q4,1,I,20151220.0,,20151228,20151228,DIR,,,,,29.0,YR,,F,N,67.1,KG,20151226.0,N,MD,US,,2015,Q4,Young Adult
118746711,11874671,1,PS,CANAGLIFLOZIN 300 MG,CANAGLIFLOZIN,1,Oral,1 PILL QD ORAL,,,D,D,,,,,,,QD,2015,Q4,Pneumonia aspiration,,2015,Q4,1,I,20151220.0,,20151228,20151228,DIR,,,,,29.0,YR,,F,N,67.1,KG,20151226.0,N,MD,US,,2015,Q4,Young Adult
118819241,11881924,1,PS,INVOKANA (CANAGLIFLOZIN) GENERIC,CANAGLIFLOZIN,1,Oral,30 PILLS 1 ADAY BY MOUTH,,,N,D,,,,30.0,DF,,QD,2015,Q4,Kidney infection,,2015,Q4,1,I,20150201.0,,20151230,20151230,DIR,,,,,56.0,YR,,M,N,220.0,LBS,20151203.0,Y,,US,,2015,Q4,Adult
118819241,11881924,1,PS,INVOKANA (CANAGLIFLOZIN) GENERIC,CANAGLIFLOZIN,1,Oral,30 PILLS 1 ADAY BY MOUTH,,,N,D,,,,30.0,DF,,QD,2015,Q4,Liver disorder,,2015,Q4,1,I,20150201.0,,20151230,20151230,DIR,,,,,56.0,YR,,M,N,220.0,LBS,20151203.0,Y,,US,,2015,Q4,Adult
118819241,11881924,1,PS,INVOKANA (CANAGLIFLOZIN) GENERIC,CANAGLIFLOZIN,1,Oral,30 PILLS 1 ADAY BY MOUTH,,,N,D,,,,30.0,DF,,QD,2015,Q4,Renal injury,,2015,Q4,1,I,20150201.0,,20151230,20151230,DIR,,,,,56.0,YR,,M,N,220.0,LBS,20151203.0,Y,,US,,2015,Q4,Adult
93001444,9300144,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 366183,,204042.0,100.0,MG,CAPSULE,QD,2015,Q4,Metastatic carcinoma of the bladder,,2015,Q4,4,F,20130315.0,20151020.0,20130521,20151023,PER,,ES-JNJFOC-20130216730,JANSSEN,,71.0,YR,E,M,Y,77.3,KG,20151023.0,,MD,ES,ES,2015,Q4,Elderly
93001444,9300144,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 366183,,76479.0,100.0,MG,CAPSULE,QD,2015,Q4,Metastatic carcinoma of the bladder,,2015,Q4,4,F,20130315.0,20151020.0,20130521,20151023,PER,,ES-JNJFOC-20130216730,JANSSEN,,71.0,YR,E,M,Y,77.3,KG,20151023.0,,MD,ES,ES,2015,Q4,Elderly
93948508,9394850,1,PS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 365186,,204042.0,,,CAPSULE,,2015,Q4,Bladder transitional cell carcinoma,,2015,Q4,8,F,20130510.0,20151023.0,20130711,20151029,EXP,,CZ-JNJFOC-20130702595,JANSSEN,,74.0,YR,E,M,Y,92.0,KG,20151029.0,,MD,CZ,CZ,2015,Q4,Elderly
93948508,9394850,2,SS,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Oral,,,,,N, 365186,,76479.0,300.0,MG,CAPSULE,QD,2015,Q4,Bladder transitional cell carcinoma,,2015,Q4,8,F,20130510.0,20151023.0,20130711,20151029,EXP,,CZ-JNJFOC-20130702595,JANSSEN,,74.0,YR,E,M,Y,92.0,KG,20151029.0,,MD,CZ,CZ,2015,Q4,Elderly
980928716,9809287,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2015,Q4,Cardiac failure congestive,,2015,Q4,16,F,20130321.0,20151030.0,20140110,20151105,EXP,,PHHO2013CA004569,NOVARTIS,,64.0,YR,,M,Y,72.3,KG,20151105.0,,MD,CA,CA,2015,Q4,Adult
980928716,9809287,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2015,Q4,Diabetic gastroparesis,,2015,Q4,16,F,20130321.0,20151030.0,20140110,20151105,EXP,,PHHO2013CA004569,NOVARTIS,,64.0,YR,,M,Y,72.3,KG,20151105.0,,MD,CA,CA,2015,Q4,Adult
980928716,9809287,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2015,Q4,Diabetic ketoacidosis,,2015,Q4,16,F,20130321.0,20151030.0,20140110,20151105,EXP,,PHHO2013CA004569,NOVARTIS,,64.0,YR,,M,Y,72.3,KG,20151105.0,,MD,CA,CA,2015,Q4,Adult
980928716,9809287,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2015,Q4,Fluid overload,,2015,Q4,16,F,20130321.0,20151030.0,20140110,20151105,EXP,,PHHO2013CA004569,NOVARTIS,,64.0,YR,,M,Y,72.3,KG,20151105.0,,MD,CA,CA,2015,Q4,Adult
980928716,9809287,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2015,Q4,Impaired gastric emptying,,2015,Q4,16,F,20130321.0,20151030.0,20140110,20151105,EXP,,PHHO2013CA004569,NOVARTIS,,64.0,YR,,M,Y,72.3,KG,20151105.0,,MD,CA,CA,2015,Q4,Adult
980928716,9809287,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2015,Q4,Oesophagitis,,2015,Q4,16,F,20130321.0,20151030.0,20140110,20151105,EXP,,PHHO2013CA004569,NOVARTIS,,64.0,YR,,M,Y,72.3,KG,20151105.0,,MD,CA,CA,2015,Q4,Adult
980928716,9809287,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2015,Q4,Pneumonia,,2015,Q4,16,F,20130321.0,20151030.0,20140110,20151105,EXP,,PHHO2013CA004569,NOVARTIS,,64.0,YR,,M,Y,72.3,KG,20151105.0,,MD,CA,CA,2015,Q4,Adult
980928716,9809287,11,C,CANAGLIFLOZIN,CANAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2015,Q4,Shock,,2015,Q4,16,F,20130321.0,20151030.0,20140110,20151105,EXP,,PHHO2013CA004569,NOVARTIS,,64.0,YR,,M,Y,72.3,KG,20151105.0,,MD,CA,CA,2015,Q4,Adult
